General Medicine: organic click to four weeks on tirzepatide

End-to-end journey for a new patient who finds General Medicine through an organic Google result, starts tirzepatide, and reaches the week-4 dose decision. The journey is mapped at the level needed to build a technology plan and an operating plan.

Terms: GM is General Medicine; PC is the state professional corporation that furnishes care; PA is prior authorization; RTPB is real-time benefit check; NCPDP is the pharmacy provider identifier; PBM is pharmacy benefit manager; HIE is health information exchange; SKU is a sellable catalog item.

Evidence and gap legend. Observed means a specific source artifact or public response was inspected; it does not mean the full patient workflow was executed. Published means a company or vendor representation, not a measured SLA. Inferred means a plausible connection between observations. Proposed means a recommended future contract or control. Recovery gap means implementation was not available in the inspected material. Mapping gap means this document omits a required step. "No field in the inspected interface" does not mean "no capability anywhere at GM." No authenticated GLP-1 encounter, prescription, claim, checkout, fulfillment, or check-in was exercised.

Evidence tags: A:A1 means step A1 in evidence-A.md; that row carries the exact code path, URL, or dataset key. [INFERENCE] marks reasoning not directly observed.


0. Summary

General Medicine sells a visit, not a drug. A patient who clicks the organic GLP-1 evaluation result lands on a page that advertises a $25 estimated copay or a $100 cash video visit, creates a phone-only account with SMS OTP, autofills identity through Verified or falls back to manual entry, optionally checks insurance, answers a server-driven screening questionnaire, and books a video visit whose availability promise is today. The clinician writes a prescription, and that prescription becomes a separate pharmacy order the patient must route and pay for. The medication price is not part of the visit purchase: LillyDirect and Amazon quote $299 for the 2.5 mg KwikPen, retail quotes $496.12 to $508.09, and the public catalog does not quote this patient's insured drug cost. Four weeks of 2.5 mg are followed by a clinician review, a new prescription for 5 mg, a new order, and a new payment. The inspected client surfaces cover clinical workflow well. No pharmacy fulfillment event contract, dose-administration event, or dedicated prior-authorization case contract was recovered in those surfaces; production capability and staff workflows outside them are not established. The money is visit fees plus a $15 lab clinical fee; the drug price is a manufacturer pass-through with no observed General Medicine margin.

Key numbers

Measure Value Basis
Time to first dose, cash retail pickup 1 to 2 days, illustrative [D:D17] [INFERENCE]: same-day video promise plus retail fill; no measured click-to-fill data
Time to first dose, cash LillyDirect or Amazon No measured click-to-first-dose bound LillyDirect publishes 3 to 5 business days after eRx receipt for verification and patient contact, then 1 to 4 days to process and ship after purchase. Transit, patient response, PA, stock and upstream care add time. Amazon timing is unverified. [PUBLIC https://www.lilly.com/lillydirect/faq]
Time to first dose, insured retail with PA 5 to 13+ days [LIVE GLP-1 guide, 2026-10-19]: PA takes several business days; [INFERENCE] on the rest
Initial visit plus first 28-day supply, cash KwikPen $399.00 $100 visit + $299 2.5 mg KwikPen. [LIVE /api/external/sku_options/300543] [LIVE /api/external/medication_option_skus/710641/cash_price]
Initial visit, first supply and Quest panel $485.58 Above plus $86.58 panel. [LIVE /api/external/lab_skus/503263]
Through purchase of the second fill $984.58 Above plus $100 week-4 visit and $399 5 mg KwikPen. Two 28-day drug purchases, not one month of medicine
Same two-fill scenario without panel $898.00 [E:E4.5] illustrative total
Same two-fill scenario with chat visits $844.58 $30 + $30 visits, same drug and lab prices. [LIVE /api/external/sku_options/300543] [LIVE /api/external/sku_options/300550] [LIVE /api/external/lab_skus/503263]
Insured path, estimated non-drug subtotal $40.00 to $65.00 plus both fills and lab liability $40 = initial $25 video copay + $15 lab review with no paid week-4 visit; $65 adds an estimated $25 follow-up. Both exclude drug and lab liability. [LIVE /api/external/sku_options/300543] [CODE components/Labs/AboutLabPricing.tsx:42-45]
First-fill drug spread $299.00 to $1,100.16 KwikPen 2.5 mg versus the default auto-injector, including the CVS upper bound. [LIVE /api/external/medication_option_skus/710641/cash_price] [LIVE /api/external/medication_option_skus/710642/cash_price] [A:A5.3]
Retail KwikPen range $496.12 to $508.09 Walgreens, Walmart, H-E-B versus CVS. [A:A5.3]
Exchange entries on the cash path 32 entries including alternative pharmacy and lab channels; 72 in the register A mandatory-party count for one journey is not established. [A:H1-H23] [B:H1-H22] [C:H1-H15] [D:H1-H18] [E:H1-H18] [F:H1-H25]; register §4
Human touchpoints 3 clinical roles, 1 dispensing pharmacist, 0 to 2 support Mapping estimate, not observed volume. Initial prescriber [D:D5], lab reviewer [C:C21], week-4 prescriber [E:E7], pharmacist [D:D16]
Visit prices $100 cash video, $25 estimated insured video, $30 cash chat [LIVE /api/external/sku_options/300543, 2026-10-19]
Lab panel 503263 $86.58 Quest, $109.67 Labcorp, $102.20 BioReference [LIVE /api/external/lab_skus/503263, 2026-10-19]; includes the $15.00 clinical fee
Cancellation fee $25.00 client fallback, video visits only, Medicaid exempt [CODE utils/cancellationFeeUtils.ts:6-26]; the policy does not publish the amount
Refund request window Visit fee 5 to 10 business days after eligible cancellation; lab refund request within 6 months if the sample is not collected, no deduction [LIVE /cancellation-policy] [LIVE /refund-policy-labs]

Top 10 risks and gaps, ranked

  1. The default Zepbound SKU costs 3.6 times the advertised price. The Lilly page says "from $299" and links to family SKU 201448, whose default child is 710642 at $1,074.09. The $299 price belongs to KwikPen SKU 710641. [A:A5.1] [LIVE /api/external/medication_option_skus/710642/cash_price = 107409]
  2. No pharmacy fulfillment event contract was recovered. The inspected client surfaces expose a state string plus cancel and switch flags; acknowledgment, rejection, dispense, shipment and possession are not represented. Production may handle these outside the inspected surfaces. [E:E1.3] [CODE lib/store/api/pharmacyOrderApi.ts:15-24]
  3. No dedicated prior-authorization case contract was recovered. RTPB returns a PA signal, but submission channel, evidence requests, approval scope, appeal and claim re-adjudication are not represented; who files and where is unverified. [D:D5.2] [LIVE /assignment-of-benefits]
  4. The privacy review is incomplete. Recovered configuration shows no consent management platform, 100% session replay with defaultPrivacyLevel: allow, and email plus phone in Segment events. Specific GLP-1 questionnaire capture, effective masking, retention, and destination access were not verified. Metabase's login shell is public; the reviewed response requires sign-in, and unauthenticated data access was not established. [A:A3.4] [F:F4.1]
  5. Billing helper literals differ from the reconstructed specification. The client checks gm_card and pharmacy_delegated; the reverse-engineered OpenAPI enum is cash, insurance, pharmacy_delegation. This is a source/specification inconsistency, not a demonstrated server defect; the authoritative BillingType is unverified. [D:D5.4]
  6. SEO sends crawlers to the wrong URLs. Sitemaps contain 3,184 /s/ URLs; the brand medication pages among them are noindex, nofollow and canonicalize to /dp/, while the indexable /dp/ pages appear in no sitemap and have no internal links. [A:A2.1]
  7. The week-4 refill window can create a gap after dose 4. One KwikPen supplies four weekly doses, used by T+21; the next dose is due T+28. GM's check-in trigger is unverified. Starting check-in and refill or PA work at T+28 can miss T+28 by 4 to 14 days. The proposed control is to start check-in and refill work at T+14 to T+18 and backward-plan from T+28. A T+21 eRx alone does not guarantee a T+28 dose for mail order, because 3 to 5 business-day verification plus processing and shipment can reach T+32. [PUBLIC Zepbound PI §2.1] [PUBLIC https://www.lilly.com/lillydirect/faq] [E:E5] [INFERENCE: proposed control]
  8. The state-to-entity and licensure mapping is unverified. Legal documents name PCs in AZ, CA, KS, ID and NJ; NPPES records show different addresses and jurisdictions; a second consented network coexists. Address differences alone do not establish a licensure or CPOM defect. [D:D0.3] [F:F7]
  9. Manufacturer savings and coordination of benefits are not represented. Eligibility, presentation, pharmacy, caps, renewal conditions, secondary claim and actual redeemed price are outside GM's public quote and were not exercised. [D:D4.4] [PUBLIC https://zepbound.lilly.com/savings]
  10. Lab pricing is inconsistent across surfaces. Cards show the test price only; checkout adds $15.00; the client falls back to $30 when the field is missing; platform_fee ranges to $40 on panel 503263 and sits outside the total. [C:C4.3] [F:F5.2]

1. Journey map

GLP-1 page

Guide

eligible

self pay

video

chat

no

yes (Rx)

parallel if ordered

if pre-start gate

LillyDirect or Amazon

retail

insured

treat

stop

A Acquisition

Entry: page or guide

B Account and intake

Coverage

C Visit checkout

Modality

D Clinical review

Eligible

Off-ramp or decline

E Pharmacy fulfillment

Labs: panel or upload

Channel

Mail order

Retail pickup

Insured: PA or claim

F Weeks 1 to 4

Week-4 review

New Rx: continue or 5 mg

Stop or switch

New fill


2. Timeline: click clock and treatment clock

Two clocks are required. E0 is the first organic click. T0 is the first actual administered dose, recorded as patient-reported or otherwise evidenced. T0 is never inferred from payment, eRx, dispense, delivery or possession. The first four injections are ordinarily T0, T+7, T+14 and T+21; the next scheduled weekly dose is T+28. Let Dstart be the elapsed days from E0 to T0. Dstart remains unknown until actual administration is reported; no bounded click-to-first-dose interval is established.

Click clock Tx clock Event Actor Gate Evidence
E0, 0 to 10 min Pre-Tx Organic result, landing page, CTA, signup redirect Patient, Google, Vercel or Netlify Page returns 200; CTA routes to /screen then /get-started [A:A1] [A:A4] [A:A6]
E0, 2 to 10 min Pre-Tx Phone, SMS OTP, session Patient, Twilio, Cognito US or territory NANP number; SMS deliverable [B:B1-B2]
E0, 5 to 20 min Pre-Tx DOB, Verified autofill or manual entry; six consent booleans; HIE notice only on the manual about-you path Patient, Verified, GM 18+; US address in 50 states plus DC; email valid [B:B3-B7]
E0, 10 to 30 min Pre-Tx Insurance discovery, optional; HIE chart review if records exist Patient, eligibility service, Metriport or Particle Payer found or self-pay chosen; consent; lookup hit [B:B9-B10]
E0, 10 to 30 min Pre-Tx State confirmation, screening questionnaire, modality and slot Patient No red flag; video or chat available in state [B:B11-B12] [C:C3-C5]
E0, 15 to 40 min Pre-Tx Visit fee paid or card saved; visit booked Patient, Stripe Slot available; card accepted [C:C6-C7]
E0 to E+1 Pre-Tx Video visit about 20 minutes, or chat in the next window; clinical decision and eRx Clinician, patient, Zoom or chat, DoseSpot, Athena Clinician joins; identity and state confirmed; no absolute contraindication [D:D3-D10]
E0 to E+3 Pre-Tx Baseline labs ordered, drawn, resulted; or external PDF uploaded Clinician, Junction, Quest or Labcorp or BioReference Requisition signed; sample collected; result reviewed if required before start [C:C15-C22]
E0 to E+1 Pre-Tx Patient opens prescription, compares pharmacies, selects channel and billing type Patient, GM, Arrive, pharmacy feeds Valid NCPDP id; price available; required labs reviewed [D:D11-D13]
Elapsed click-to-fulfillment time unknown; channel-specific planning estimates only Pre-Tx Pharmacy verification, checkout, claim or PA, shipment or pickup Patient, pharmacy, PBM, PA team, carrier Rx received; payment or claim; PA approved or cash chosen; stock available [D:D14-D17] [PUBLIC https://www.lilly.com/lillydirect/faq] [INFERENCE: no measured bound]
E + Dstart T0 Dose 1, 2.5 mg, patient-reported. Possession, package condition, device and supplies confirmed first Patient, pharmacist, care team Drug in hand; presentation-specific instruction; T0 recorded or explicitly unknown [E:E1.4-E2] [PUBLIC Zepbound PI §17] [INFERENCE: proposed T0 control]
E + Dstart + 7 T+7 Dose 2, 2.5 mg Patient Weekly schedule [E:E4]
E + Dstart + 14 T+14 Dose 3, 2.5 mg; proposed check-in and refill work start Patient, GM One dose remains after this; start refill and PA work now [E:E5] [INFERENCE: proposed control]
E + Dstart + 18 to 20 T+18 to T+20 Proposed check-in submission and clinician review; dose decision Patient, clinician Questionnaire, optional labs, interval history; reviewer available [E:E6-E7] [INFERENCE: proposed control]
E + Dstart + 21 T+21 Dose 4, final 2.5 mg dose from the pen; refill work should already be underway Patient, clinician, DoseSpot, pharmacy Review complete; new strength prescribed; PA checked if insured. A T+21 eRx alone does not guarantee T+28 for mail order [E:E8] [PUBLIC Zepbound PI §2.1] [PUBLIC https://www.lilly.com/lillydirect/faq] [INFERENCE: proposed control]
E + Dstart + 28 T+28 Dose 5, first 5 mg dose, if the second box is in hand; otherwise a gap Patient Box delivered or picked up by T+27 [E:E8] [INFERENCE]
E + Dstart + 28 or later T+28+ Fallback review if the proposed T+14 to T+21 window was missed Clinician, care team Reconcile remaining pens, missed doses and restart plan [E:E5-E7] [PUBLIC Zepbound PI §2.3]

Timing note: only the video availability_promise: "today", the chat next-slot timestamp, LillyDirect's published minimum of 3 to 5 business days for verification plus 1 to 4 days to process and ship after checkout, the PA claim of "several business days", and the lab claim of 48-hour results are published. Lilly asks patients to allow a minimum of 3 to 5 business days for verification; most prescriptions are processed and shipped within 1 to 4 days of checkout. Transit and upstream delays are additional; these are not maximum delivery SLAs. Business days and calendar days are not interchangeable. No measured click-to-first-dose bound is established. The T+14 to T+18 refill start is a proposed operating control, not observed GM behavior, and a T+21 eRx is not sufficient to guarantee a T+28 mail-order dose.


3. Stage-by-stage walkthrough

A. Acquisition

Headline: one organic doorway works, and it sells a visit rather than a drug.

Get started

Guide

Compare

Organic click

GLP-1 page 300543

Entry

Signup

GLP-1 article

Pharmacy compare

Price and form check

Account handoff

# Patient sees or does GM system or route Data Outside party Evidence
A1 Clicks an organic result for a GLP-1 query /s/glp-1-medication-evaluation/300543 on Vercel; article on Netlify Referrer, landing URL, IP, nile_ld_key UUID, isAuthenticated=false Google, Bing, DuckDuckGo, CloudFront, Vercel or Netlify [A:A1]
A2 Reads hero, price, FAQ, testimonials SkuRefreshRenderer; category page components page_view_id, landing_page_loaded, dwell frames, LCP, cache hit Segment, Datadog, LaunchDarkly [A:A2]
A3 Nothing visible; attribution parameters are persisted when present useAttributionTracking; POST /api/campaign-touches only when utm_source and an anonymous id exist UTMs, optional paid click IDs, _fbc, synthetic _fbp, in-app browser. An untagged organic landing creates no campaign touch Google, Microsoft, Meta, Kargo, OpenAI ads only when present; Segment [A:A3]
A4 Chooses Get started, Book a visit, a related service, or search SkuDetailCta, CategoryHeader, ServiceItemCard, StoreSearchDrawer sf_clicked_sku, sku_page_cta_clicked, new_storefront_request_medication_clicked Segment, Datadog [A:A4] [A:A11]
A5 Is redirected to signup, or to login on /visit Edge middleware 307; sku_id and redirect_url cookies SKU id, absolute return URL, auth flag None [A:A6]
A6 Enters phone, receives OTP /get-started, /get-started/verify Phone, OTP funnel events Twilio, AWS Cognito [A:A7] [B:B1-B2]
A7 Is returned to the booking screen, consumer not recovered so inferred Cookie consumer not recovered signup_complete, alias, identify, merge_identity, patientId Segment, Datadog [A:A8]
A8 On a medication page, switches dose form or strength /dp/<slug>/<sibling_sku_id> via replaceState; price refetch New SKU id and price; no new pageview None [A:A10]
A9 Searches "tirz", "zep", "glp" /api/external/search/suggestions, /store/search Raw query and suggestion array sent to Segment Segment [A:A11]
A10 Opens Browse pharmacies: API returns about 52 rows, UI caps display at 20 interleaved rows pharmacy_comparisons API; Maps JS; UNIVERSAL_SEARCH_PHARMACIES_DISPLAY_LIMIT = 20 Coordinates, ZIP, NCPDP id, chain, distance, total_price_cents Google Maps, LillyDirect, NovoCare, Amazon, retail chains [A:A12] [CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:12,154]
A11 Lands on the Lilly co-branded page /p/lilly/weight-loss landing_page_loaded with page_id=lilly_weight_loss; ad landing event Lilly, Segment [A:A13]
A12 Reads the GLP-1 guide and clicks Book visit Astro article with absolute link Outbound click; rel=noreferrer removes the referrer GA4, OneSignal, Sanity, Netlify [A:A14]

Decision points

  • Visit or medication: the GLP-1 evaluation is category: condition and sells a visit. Medication SKUs sell a drug but cannot be bought before a visit.
  • Cash or insurance: the storefront has no global toggle. Condition and medication SKUs go straight to the booking screen; labs use an insurance drawer.
  • Retail or direct: the compare drawer pins LillyDirect, NovoCare, and Amazon above retail. The price gap on the 2.5 mg pen is $299 versus $496.12 to $508.09.
  • Which Zepbound form: the family page defaults to the auto-injector at $1,074.09. The KwikPen at $299 requires a dose-form switch or the LillyDirect pharmacy page.

B. Account and intake

Headline: phone-only signup, third-party identity autofill, six consent booleans plus an HIE notice, then a server-driven questionnaire.

yes

no

check

in network

not found

self pay

Phone

SMS OTP

Date of birth

Verified match

Review autofill

Manual about you

Six consents and patient record

Insurance

Eligibility service

Result

Visit options

Self pay

# Patient sees or does GM system or route Data Outside party Evidence
B1 Step 1 of 3, enters a US mobile number /get-started, PhoneInput, AuthProvider.login POST /auth/initiate, phone in localStorage, otp_send_requested Twilio, Cognito [B:B1]
B2 Enters a 6-digit code /get-started/verify OTP, Cognito session, HttpOnly cookie, isAuthenticated=true mirror Cognito, Twilio [B:B2]
B3 Step 3 of 4, enters date of birth /get-started/date-of-birth {birth_date} only; no SSN field Verified [B:B3]
B4 Sees autofilled name, address, sex, email; no HIE notice observed on this path /get-started/review-info Name, DOB, sex, email, up to 7 addresses Verified [B:B4-B5]
B5 Manual about-you form with HIE notice and opt-out link /get-started/about-you Legal name, address, email, sex at birth; HIE consent by continuing, PDF opt-out, no boolean field Google Places, email validation vendor [B:B6]
B6 Accepts terms and continues POST /api/external/patients Identity, six consent booleans hard-coded true, no HIE boolean, all UTMs and click IDs, signup_id, signup_sku_id, signup_channel Segment, Datadog [B:B7]
B7 Lands on /welcome or /ai/onboarding Auth-gated route; content not recovered Conditional browser telemetry only: if SignupTracker mounts and its user, analytics and local-guard checks pass, it attempts signup_complete and identify, which carry email and phone; alias receives only the user ID. Sending on this path was not observed. Patient creation is the authoritative record Segment, Datadog [B:B8] [CODE components/SignupTracker.tsx:16-98]
B8 Insurance: picks a plan, enters member ID, or photographs the card /insurance; eligibility enqueue or sync Payer, member ID, group, card images, copay, network status Verified 1-Click Health (candidate), Waystar (inferred), payer, OCR vendor, S3 [B:B9]
B9 Reviews conditions, medications, allergies, procedures /health-history/{step}/add FHIR records tagged metriport, particle, or customer Metriport, Particle [B:B10]
B10 Confirms physical state before screening /location-confirmation appointment_location_state None [C:C5] [D:D2]
B11 Answers the GLP-1 screening questionnaire, one question per screen /questionnaire/{id}/{n} Answers, progress, off_ramp_type in emergency, urgent, high_risk, requires_triage, unable_to_treat, different_sku; emergency branch None [B:B11] [CODE lib/analytics/questionnaireInterstitialAnalytics.ts:3-9]
B12 Picks video or chat and a time /options, skuOptionsApi Modality, slot, price, insurance_status None at selection; Stripe at payment [B:B12]
B13 Completes history questionnaire or chart review before the visit /questionnaire/{history_id}, /health-history Pre-visit requirements and responses Metriport, Particle [B:B13]

Decision points

  • Identity match or manual entry: a Verified miss produces no error message; the patient silently lands on the manual form.
  • Insurance or self-pay: an eligibility failure offers "Try another insurance" or "Continue without insurance" at $100.
  • Chat allowed or not: chat is omitted in AL, AR, DE, FL, KS, LA, MN, MS, NJ, NM, RI, and WV.
  • Red flag or clear: the questionnaire can off-ramp to the care team, another SKU, or an unavailable screen.

C. Checkout and labs

Headline: three separate money events, and a lab fee that is real at $15 but fallback-priced at $30.

video

chat

yes

upload

no

Visit options

Modality

Video 100 or 25

Chat 30 cash

Slot and payment

Booked visit

Labs required

Panel 503263

External PDF

No labs

Draw and result

Pharmacy order later

# Patient sees or does GM system or route Data Outside party Evidence
C1 Sees Video $25 estimated or $100 cash; Chat $30 cash /s/glp-1-medication-evaluation/300543 sku_id, price option None [C:C1]
C2 Taps Get started; screening flow opens /s/{slug}/{id}/screen ref, practiceId, page view id None [C:C2]
C3 Answers screening questions Questionnaire engine screening_questionnaire_id=11340c6b..., answers None [C:C3]
C4 Chooses billing: insurance, cash, or MDSave where offered /visit/{id}/options billing_type, price cents, insurance_status, slots MDSave on some in-person SKUs only [C:C4]
C5 Picks a slot; sees the 24-hour cancellation rule /visit/{id}/schedule scheduled_time, clinician id, cancellation_fee_policy_applies None [C:C5]
C6 Sees Confirm and Book, due today, FSA/HSA label /visit/{id}/payment payment_method_id, price_guaranteed, agreement flags Stripe [C:C6]
C7 Adds a card if none on file SetupIntent then POST /visits/book client_secret, brand, last4, expiry Stripe [C:C7]
C8 Gets confirmation and a Zoom link /visits/{id} visit_id, state, meeting_url Zoom, Twilio, email provider [C:C8]
C9 Cancels or reschedules Visit state machine; Visitron fee waiver cancellation_reason, cancellation_fee_amount_cents Stripe [C:C9]
C10 Later sees the prescription and pharmacy options ensure_pharmacy_order; /orders/pharmacy/{id}/options pharmacy_order_id, medication_option_sku_id, NCPDP id, arrive_rtpbi_inquiry_id Arrive Health, DoseSpot [C:C11-C12]
C11 Chooses insurance copay, GM card at counter, or cash pre-pay checkout, checkout_with_insurance, checkout_for_pharmacy_delegation billing_type, payment method, gm_card BIN/PCN/group/member Stripe, pharmacy [C:C13-C14]
C12 Orders a baseline lab panel or uploads recent labs Lab SKU PDP; /account/medication-check-in/labs lab_sku_ids, lab_order_id, file ids Junction, Quest, Labcorp, BioReference, S3 [C:C15-C22]
C13 Sees test price plus "$15 clinical review added at checkout" LabPanelPricing test_price, clinical_fee, clinical_fee_enabled None [C:C18]
C14 Books the draw; walks in or schedules /s/{slug}/{id}/start; Junction appointment lab_order_id, accession, scheduled_at, lab_vendor_name Junction, lab [C:C19-C20]
C15 Gets results in dashboard, Updates, or PDF /account/labs, Updates feed status, report_url, results_count, abnormal_results_count Lab, clinician [C:C21]
C16 Week 4: books follow-up or completes check-in 300550; /prescriptions/{id}/check-in sku_id=300550, billing type, next fill Stripe, clinician [C:C23-C24]

Decision points

  • Insurance in network: $25 estimate, preselected if cheaper.
  • Out of network: book without insurance or switch to chat.
  • Medicaid with no capacity: "Text us and we'll help you find a time."
  • Lab self-bookable with insurance: insurance_orderable is true for 503263; false for 500114, 500049, and 500001.
  • Lab conditions screen: continue without insurance, continue with insurance anyway, or book a video visit.
  • Abnormal result: clinician outreach; a paid Lab Results Review visit exists at $100 or $25.

D. Clinical review and prescribing

Headline: a shift-based clinician writes the prescription in Visitron, and the pharmacy leg starts as a separate patient task.

no

yes

yes

no

Appointment

Chart prewarm

Video or chat visit

Safety and indication review

Eligible

Decline or refer

Care plan

Draft and finalize eRx

RTPB and formulary

Sign encounter

Sync to Athena

Pharmacy order created

PA signal

PA path

Cash or claim

# Patient sees or does GM system or route Data Outside party Evidence
D1 Picks modality and slot; pays or saves a card, capture timing inferred /options; visits/create, booking_selection, payment_method, book sku_id, modality, slot, price, state Stripe [D:D1]
D2 Confirms physical location /location-confirmation State, practice_id, clinician pool None [D:D2]
D3 Waits for the visit link or chat window Visitron appointment and chat queues appointment_id, visit_type, meeting_url Zoom, Twilio [D:D3]
D4 Nothing; clinician opens the chart applyAppointmentLatestPrewarm, getPatientChartContext, triggerMetriportSync, getQuestionnaireCodes HIE history, prior encounters, meds, allergies, answers Metriport, Particle, Athena [D:D4]
D5 Talks or messages for 15 to 45 minutes getDraftEncounter, updateDraftEncounter, getChatHistory, getNablaStatus Transcript, note draft, diagnoses, orders Zoom, Zendesk, Nabla [D:D5]
D6 Describes weight history, comorbidities, prior GLP-1 use Diagnosis and order search BMI, comorbidities, contraindications, labs None [D:D6]
D7 Later sees care-plan phases and check-ins createCareJourney, changePathway, changePhase pathway_id, phase_id, modality, days supply None [D:D7]
D8 Nothing; later sees the prescription createDraftPrescription, finalizeDraftPrescription; DoseSpot SSO Drug, strength, form, quantity, days supply, refills, SIG DoseSpot [D:D8]
D9 Sees "available after visit" or a copay later launchInsurancePrice, launch_benefit_inquiry; consumer poll Copay tier, deductible, formulary, PA flag, inquiry id Arrive Health, DoseSpot, PBM [D:D9]
D10 Sees the signed care plan and next steps confirmCarePlan, publishAppointmentDraftEncounter, syncEncounterToAthena Signed note, athena_id, next-step review Athenahealth [D:D10]
D11 Opens the prescription and taps order ensure_pharmacy_order care_action_prescription_id, pharmacy_order_id, state None [D:D11]
D12 Compares pharmacies and selects one pharmacy_comparisons, select_pharmacy NCPDP id, price, distance, fulfillment_owner LillyDirect, NovoCare, Amazon, retail [D:D12]
D13 Chooses cash, insurance, or pay at counter PUT /api/external/pharmacy_orders/{id} with {billing_type} billing_type; payment method and price are separate fields Stripe, pharmacy [D:D13] [CODE lib/store/api/pharmacyOrderApi.ts:34-42]
D14 Pays or shows the GM card checkout, checkout_with_insurance, checkout_for_pharmacy_delegation, gm_card payment_intent, gm_card fields Stripe, pharmacy [D:D14]
D15 Nothing; pharmacy receives the Rx DoseSpot eRx to the selected NCPDP id Rx payload, demographics, prepaid status DoseSpot, pharmacy [D:D15]
D16 Gets a pharmacy text, checkout link, or pickup notice Pharmacy system Rx status, copay, PA status, savings, shipment LillyDirect dispensing pharmacy, Amazon, retail [D:D16]
D17 Receives the package or picks up No GM shipping object recovered Pharmacy-side tracking is described; GM tracking visibility outside the inspected interfaces is unverified Carrier, pharmacy [D:D17]
D18 At T+14 to T+28, sees check-in and next-step cards; GM trigger unverified care_journey/next_steps, check-in Criteria id, responses, lab order, deadline None [D:D18] [INFERENCE: proposed window]
D19 Week-4 visit or review; dose decision getClinicianReviews, applyReview, changePhase, renewal New dose, new Rx, phase change, days supply Clinician, Athena [D:D19]
D20 Chooses pharmacy and pays again for 5 mg Same as D11 to D17 New order, new SKU, new price, possibly new PA All pharmacy parties [D:D20]

Decision points

  • Zepbound or Mounjaro: separate indications. Zepbound weight management uses BMI 30 or 27 with a comorbidity; Mounjaro is type 2 diabetes and also has a cardiovascular-risk indication in specified adults with T2D. GM is adult-only and no pediatric redirect was observed; do not apply Zepbound BMI or cash rules to Mounjaro.
  • Compounded tirzepatide: no SKU was observed in the inspected public catalog, search index or recovered source. Compounded products are outside this mapped branded path; availability elsewhere is not established.
  • Form: KwikPen, auto-injector, or vial. The default PDP form is the auto-injector at $1,074.09; the vial has no cash price.
  • Contraception: tirzepatide delays gastric emptying and can reduce oral contraceptive exposure, most after the first dose and each escalation. Counsel on a non-oral method or backup for 4 weeks after initiation and after each escalation; no structured field was observed and the counseling should repeat at week 4.
  • Safety review: separate absolute label contraindications (MTC or MEN2 history, serious hypersensitivity) from warnings and precautions (gastroparesis, pancreatitis, gallbladder, kidney injury, hypoglycemia with insulin or secretagogues, retinopathy, pregnancy, anesthesia aspiration). Record the source version, finding, clinician decision and advice. [PUBLIC Zepbound PI §§4-5, 7-8]
  • Cash or insurance: cash may use eligible retail pay-ahead, a pharmacy-counter cash or discount price, or an eligible manufacturer direct-pay program. Insurance needs a claim and may need a PA. [D:D4.3] [LIVE https://generalmedicine.co/resources/compare-medication-prices-before-you-order-and-pay-ahead-for-easy-pickup]
  • PA or no PA: RTPB returns a requirement; no dedicated PA case or submission contract was recovered. [D:D5.2]
  • Week 4 for a new labeled Zepbound start: review at the end of four weeks of 2.5 mg and ordinarily proceed to 5 mg. Intolerance, interruption, extended initiation, switching or stopping require clinician-directed decisions; 2.5 mg is not a maintenance dose and no lower-than-2.5 mg starter dose is labeled. [PUBLIC Zepbound PI §2.1]

Mounjaro adult T2D branch

  • Indication: glycemic control in adults with type 2 diabetes, plus cardiovascular-risk reduction in specified adults with T2D; there is no BMI threshold for the T2D indication. [PUBLIC Mounjaro PI §1]
  • Product route: separate NDC, presentation, quote, benefit or PA check, pharmacy and savings eligibility. Zepbound's $299/$399/$449 self-pay ladder does not apply. [D:D4.2]
  • Observed GM route: retail only at $552.28 Walgreens and $565.63 CVS, a 2026-10-19 snapshot that must be re-quoted. [LIVE /api/external/medication_option_skus/710655/cash_price]
  • Pediatric use: the Mounjaro label includes patients 10 years and older, but GM's observed service is 18+ with no pediatric redirect. Treat pediatric requests as out of scope for this path. [PUBLIC Mounjaro PI §1] [B:§5]
  • First-month dosing: start 2.5 mg once weekly. After at least 4 weeks, increase to 5 mg if additional glycemic control is needed; further 2.5 mg increments require at least 4 weeks on the current dose. Maximum 15 mg weekly in adults. [PUBLIC Mounjaro PI §2.1]
  • Monitoring and handoff: record baseline glucose or A1c, diabetes medications, hypoglycemia risk, renal function and retinopathy history. Document any insulin or secretagogue dose reduction and the glucose-monitoring plan. At the first review, record glucose response, adverse effects, adherence and the clinician's continuation or escalation decision. [PUBLIC Mounjaro PI §§5.3, 5.5, 5.7, 8]
  • Benefits: re-check the T2D indication, NDC, quantity, PA and savings eligibility separately from the Zepbound weight-management path. [D:D4.2]

E. Pharmacy fulfillment and first dose

Headline: the prescription leaves GM and the patient becomes the integration.

LillyDirect

Amazon

retail

insured

yes

no

yes

no

Rx

Channel

Mail order

Mail order

Retail pickup

Benefit check

Pharmacy checkout

PA required

PA wait

Approved

Cash fallback

Claim

Pickup

Possession and training

First dose T0

# Patient sees or does GM system or route Data Outside party Evidence
E1 Sees the care plan and prescription card /account, /account/care-plans, /account/next-steps care_id, plan_id, plan state, remainingMessage None [E:E1]
E2 Chooses pharmacy and payment mode ensure_pharmacy_order, pharmacy_comparisons, select_pharmacy NCPDP id, billing_type, prices, state Arrive, pharmacies [E:E1.1]
E3 Sees LillyDirect and Amazon at $299; retail at $496.12 to $508.09 Compare drawer Chain, distance, price, fulfillment_owner LillyDirect, Amazon, retail [E:E1.2]
E4 Pays in app, pays at counter, or presents the GM card Stripe checkout; gm_card payment_method_id, BIN/PCN/group/member, submission state Stripe, pharmacy [E:E1.3]
E5 Gets a "prescription sent" notice; picks up or receives the box No first-dose screen or event recovered Prescription sent; no dose-taken timestamp recovered Pharmacy, carrier [E:E1.4]
E5.1 Confirms possession, brand, strength, presentation, quantity, directions and package condition Proposed possession reconciliation; no GM field observed Presentation, quantity, condition, discrepancy Dispensing pharmacy [INFERENCE: proposed control]
E5.2 Confirms needles, syringes and sharps plan; receives presentation-specific instruction and teach-back Proposed; pharmacist and prescriber own counseling. AI is not a primary trainer Presentation, supplies, ability, training version Pharmacy, clinician [PUBLIC Zepbound PI §17] [E:E2] [INFERENCE: proposed control]
E5.3 Reports actual first dose as T0, or states that start is delayed or declined Proposed T0 record; no administration endpoint observed first_dose_administered_at, source, delay reason Patient, care team [INFERENCE: proposed control]
E6 Learns injection from the label, IFU, pharmacist or clinician; AI is a navigation aid, not a trainer formatInstructions; patient_instructions; messaging SIG text, presentation, needle requirements Pharmacy, Lilly [E:E2] [PUBLIC Zepbound PI §17]
E7 Messages the care team or General AI about side effects Message Center if flag on; otherwise SMS; /ai Conversation, subject, response_expectation, AI messages Twilio, Zendesk, Braintrust [E:E3]
E8 Takes doses 2, 3, 4; no GM dose event recovered None No dose event observed in inspected client; production may differ None [E:E4]
E9 Gets a refill reminder or check-in card earliest_fill_date, criteria_deadline, NextStepCard Dates, pending criteria, deadline None [E:E5]
E10 Completes check-in questionnaire and optional labs /account/medication-check-in; care_journey/* Actionable count, estimated minutes, item type, status Junction, lab, S3 [E:E6]
E11 Waits for clinician review Visitron generateNextStepReview, applyReview, confirmNoChange Review fields proposed_json, final_json, rationale and phase are dossier-attributed, not first-party contracts Clinician [E:E7] [F:F3.3]
E12 Gets a new 5 mg prescription and pays $399 New PharmacyOrder for new SKU New order id, SKU, price, PA requirement Pharmacies, payer [E:E8]
E13 For the 7.5 to 15 mg KwikPen offer, completes the next qualifying purchase within 45 days of delivery or receipt of the previous fill Refill or renewal next step due_date, on_next_step, refills left, previous receipt date LillyDirect [E:E9] [PUBLIC https://zepbound.lilly.com/savings/terms-and-conditions]
E14 Sees month-1 charges /account/orders, pharmacy invoice Billing type, cash and insurance price, clinical fee, invoice Stripe, pharmacy [E:E10]
E15 Cancels, switches pharmacy, declines renewal, or stops pharmacy_orders/{id}/cancel, renewal decline Cancellation reason, cancel and switch flags Support, pharmacy [E:E11]
E16 Does not log weight, doses, or vitals No endpoint or device integration observed Weight only if typed into a questionnaire None [E:E12]

Decision points

  • Mail order or retail: for the starter KwikPen snapshot, Austin retail quotes are $496.12 to $508.09 versus $299 direct, about 1.66 to 1.70 times. Different presentations and strengths need separate comparisons. Pickup may avoid transit, but stock and processing determine timing; no comparative delivery-performance distribution was measured.
  • Pre-pay or pay at counter: pre-pay works at eligible retail only, not mail order.
  • KwikPen or auto-injector: a $299 versus $1,074.09 decision that the storefront default gets wrong.
  • Refill or renewal: same-strength refills depend on the prescription, pharmacy and payer rules; a new strength needs an appropriate new prescription. [E:E9]
  • 45-day condition: for the 7.5, 10, 12.5 and 15 mg KwikPen purchase offer only, the next qualifying purchase must be completed within 45 days of delivery or receipt of the previous fill. The 2.5 mg and 5 mg starter prices are not conditioned on this window. [PUBLIC https://zepbound.lilly.com/savings/terms-and-conditions]

F. Weeks 1 to 4 and the week-4 step-up

Headline: the clinical loop is instrumented; the patient's month is not.

continue

escalate

stop

T0 dose 1

T+7 dose 2

T+14 dose 3

Proposed check-in unlock

T+18 to T+20 review

Decision

2.5 mg Rx

5 mg Rx

Stop or switch

New order

T+21 dose 4

T+28 dose 5 or gap

Transition plan

# Patient sees or does GM system or route Data Outside party Evidence
F1 Home dashboard shows care plan and next steps dashboard/show, next_steps/by_care, next_step_cards Plan state, next steps, deadlines None [E:E1]
F2 Receives in-app, email, and SMS notices Updates feed; email; Twilio event_type, notifiable_type, unread, sla_promise Twilio, email vendor [E:E14]
F3 Asks General AI about missed doses or side effects /ai, /ai/chat, /ai/health-records Consent, messages, feedback, Metriport prewarm LLM provider, Metriport, Braintrust [E:E13]
F4 Reports severe symptoms or asks for a dose change Message Center; 300348 side effect; 200010 adjustment Conversation, visit booking, clinical note Twilio, Zendesk, clinician [E:E16]
F5 Completes the medication check-in; proposed unlock at T+14 to T+18, GM trigger unverified /account/medication-check-in Answers, progress, estimated_minutes None [E:E6] [INFERENCE: proposed control]
F6 Completes or uploads labs if required /labs, /labs/upload; care_journey/lab_bundle Lab order, file id, S3 state Junction, lab, S3 [E:E6]
F7 Waits for a clinician decision Visitron pending review Review fields proposed_json, final_json, decision and rationale are dossier-attributed Clinician [E:E7] [F:F3.3]
F8 Gets 2.5 mg continued as a clinician deviation, or the standard 5 mg, or a stop changePhase, changePathway, renewal ops New phase, strength, Rx, days supply Athena, DoseSpot [E:E7] [PUBLIC Zepbound PI §2.1]
F9 Re-selects pharmacy and pays for the new strength New order and checkout New SKU id, NCPDP id, price, PA Pharmacies, payer [E:E8]
F10 Refills or renews; may need a new PA Refill order or NextStep::PrescriptionRenewal due_date, on_next_step, open_to_renew Pharmacy, PBM [E:E9]
F11 May stop without a formal workflow Cancellation and renewal decline Reason, flags, no subscription state Support [E:E11]
F12 Remains outside any adherence measurement in the inspected client No dose log, weight log or device sync observed None None [E:E12]

Decision points

  • For a new labeled Zepbound start, ordinarily proceed from 2.5 mg to 5 mg after four weeks. Continuing 2.5 mg, extending initiation, lowering, switching or stopping are clinician-directed deviations; 2.5 mg is not a maintenance dose and no lower-than-2.5 mg starter dose is labeled. [PUBLIC Zepbound PI §2.1]
  • Questionnaire only, labs, or a paid visit: the GLP-1 criteria set and blocking rule are server-side and unobserved.
  • Refill timing: one KwikPen supplies four weekly doses; the fourth is used at T+21 and the next dose is due at T+28. Start check-in and refill or PA work at T+14 to T+18 and backward-plan from T+28. A T+21 eRx alone does not guarantee T+28 for mail order; GM's actual trigger is unverified. [PUBLIC https://www.lilly.com/lillydirect/faq] [INFERENCE: proposed control]
  • Adherence: no dose-administration event was recovered, so a stopped patient and a stable patient can look alike except through refill cadence or self-report. [E:E4]

3.7 Product safety, dispensing and first-dose readiness

These are proposed controls. GM enforcement is not observed.

Step Patient sees or does Responsible handoff Proposed record or closure What is known Evidence
Safety review before prescribing Discusses personal or family MTC or MEN2, serious hypersensitivity, pregnancy plans, GI history, diabetes drugs and other medications Licensed prescriber reviews product-specific contraindications, warnings and interactions Reviewed source and version, findings, decision, counseling, follow-up PI content is established; exact GM questionnaire and rules are unrecovered. Do not relabel every warning as a contraindication [PUBLIC Zepbound PI §§4-5, 7-8] [D:D6]
Contraception and planned procedures Receives oral-contraceptive and procedure or anesthesia counseling when applicable Prescriber to patient; pharmacist reinforces Counseling documented, including non-oral method or barrier method for 4 weeks after initiation and each escalation PI supports the counseling; structured GM enforcement unknown [PUBLIC Zepbound PI §§7.2, 8.3, 17]
Pregnancy and interval review Reports pregnancy, pregnancy plans or lactation at start and at follow-up Prescriber; obstetric coordination when needed Zepbound: discontinue when pregnancy is recognized. Mounjaro: product-specific diabetes and obstetric risk-benefit review. Interval pregnancy question at each escalation PI supports product-specific actions; GM workflow unknown [PUBLIC Zepbound PI §8.1] [PUBLIC Mounjaro PI §8.1]
Glycemic medication plan Reports insulin, sulfonylurea or other glucose-lowering drugs Prescriber and pharmacist Baseline glucose or A1c, hypoglycemia risk, whether insulin or secretagogue dose reduction is indicated, monitoring plan Labels require counseling and monitoring; no structured GM field observed [PUBLIC Zepbound PI §§5.7, 7.1] [PUBLIC Mounjaro PI §§5.3, 5.7]
Narrow-therapeutic-index oral drugs Reports warfarin, levothyroxine or other narrow-TI medicines Prescriber and pharmacist Delayed gastric emptying noted; monitoring or dose adjustment plan recorded Label interaction section supports the risk; GM workflow unknown [PUBLIC Zepbound PI §7.2]
Dispensing product reconciliation Confirms brand, strength, presentation, quantity, directions and channel Prescriber and eRx to dispensing pharmacist to patient Accepted or corrected Rx and dispensed presentation; mismatch stays open Gifthealth reports quantity, directions and formulation as rejection causes; GM route resolution unverified [PUBLIC https://www.gifthealth.com/faq-topics/prescriptions-getting-started] [D:D16]
Supplies and training Confirms needles or syringes and sharps plan; receives device-specific instruction and ability assessment Dispensing pharmacist and prescriber Training version, received presentation, supplies, ability or assistance needed; retraining on presentation change PI requires presentation-appropriate training. No completed GM training event observed. KwikPen needs a separate pen needle; no needle SKU was observed [PUBLIC Zepbound PI §17] [E:E2] [E:§6 q14]
Shipment or pickup exception Reports wrong item, delay, damage, suspected temperature problem or non-possession Pharmacy handles product and dispensing decision; GM coordinates clinical consequences Tracking if available, possession report, issue, pharmacy response, replacement or clinical plan Use the received presentation's current label. Do not infer safety from a carrier scan. GM visibility unknown [D:D5.3] [PUBLIC Zepbound PI §16.2] [INFERENCE: common practice]
Cold chain and in-use storage Stores and uses the received presentation correctly Pharmacist reinforces at dispensing; patient follows IFU Refrigerate at 2 to 8 C, never freeze; room temperature means no more than 30 C. Total room-temperature exposure is cumulative. Never use a previously frozen product. Single-dose pen or vial: up to 21 total days at 30 C or below, then discard. Unopened multi-dose vial or KwikPen at room temperature: discard after 30 days. Opened multi-dose vial or KwikPen: discard after 30 days at room temperature, 30 days after first use, or after 4 weekly doses, whichever comes first Label supplies concrete limits; no GM temperature-tracking feed recovered, production visibility unknown [PUBLIC Zepbound PI §16.2]
First-dose start Reports actual start or explains delay or decline Patient to care team T0 with source, or explicit unknown or not started; next-dose plan Proposed control; no administration endpoint observed [INFERENCE: proposed control]
Safety event and product complaint Receives urgency-appropriate clinical direction Licensed clinician first; reporting owner separately reviews Lilly or FDA reporting Clinical event and action, product and exposure details, report reference if submitted, follow-up PI reporting routes observed; GM reporting practice unknown. Reporting is not a substitute for emergency care [PUBLIC Zepbound PI §17] [E:E16]

3.8 Prior authorization and claim closure

A benefit inquiry is not a PA submission, an approval is not a paid claim, and a paid claim is not dispense. This lifecycle is proposed and must be reconciled with existing DoseSpot, payer portal, Athena and staff processes before building a second queue.

State or event Owner and handoff Minimum record Exit or failure Evidence
Benefit signal or claim rejection received Pharmacy or benefit service to a verified PA intake owner Patient, prescription, product and NDC, payer or PBM, rejection or PA signal, source time Accepted case ownership, not just a patient notification [D:D5.2] [D:D9]
Requirements and coverage checked PA specialist plus prescriber Plan criteria, evidence needed, authorization scope, urgency, submission channel Missing-evidence task or ready-to-submit; channel currently unknown [D:D5.2] [F:F6]
Submitted Verified submitter to payer or PBM Submission timestamp, external receipt or case number, document versions Acknowledged submission, not inferred from a button click [INFERENCE: proposed control]
Additional information requested Payer to case owner to prescriber or patient Request, deadline, owner, response receipt Response accepted or deadline escalation [INFERENCE: proposed control]
Decision Payer to case owner to patient or pharmacy Approval or denial reason, covered strength and form, quantity, effective and expiry dates, appeal rights Approval is not yet a successful fill [INFERENCE: proposed control]
Re-adjudicated Pharmacy to PBM Actual claim outcome, patient liability, savings result Patient accepts payable amount or chooses another authorized path [D:D5.3]
Savings and COB Pharmacy benefit service Program and offer version, product and presentation, approved-use eligibility, government-program exclusion, permitted pharmacy, quantity and days supply, primary claim outcome, secondary claim result, remaining cap, expiration, patient's accepted price Missing eligibility or denied secondary claim explained before a replacement cash price [PUBLIC https://zepbound.lilly.com/savings/terms-and-conditions]
Denial, cash, appeal or switch Prescriber, patient and PA owner Clinical choice, explicit financial acceptance, appeal deadline, replacement prescription if needed Do not silently convert to cash or presume reimbursement permitted [D:D5.2] [E:E16]
Dispensed, reversed or abandoned Pharmacy to care coordination, where supported Dispense or reversal evidence, patient possession, closure reason Case closure with evidence; abandoned is not successful care [E:E1.3]
Next strength or renewal Prescriber, PA owner and pharmacy Remaining authorization and refills, next-dose date, product change, lead time Resolve before a planned interruption; do not auto-escalate [E:E8] [E:E9]
Task Accountable role, proposed Required handoff or artifact Current evidence limit Evidence
Encounter location and clinical authority Clinical operations or licensed clinical lead Current physical state, callback, clinician eligibility, furnishing entity, collaboration requirements. If location changes, authority expires, or no eligible clinician exists, hold unsupported care and route to a licensed reviewer. Pharmacy refusal of an NP prescription escalates to the licensure manager Public modality availability and location route observed; backend enforcement unverified [B:B11] [C:C5] [F:F8]
Self-pay estimate Billing and compliance owner for the furnishing provider Request or scheduling trigger, uninsured or self-pay status, issuing entity, dated itemized estimate, delivery evidence, dispute intake. Scheduling 3 to 9 business days ahead: deliver within 1 business day. 10 or more business days ahead, or requested before scheduling: within 3 business days. Separately billed labs and pharmacies may issue separate estimates Prices observed; a compliant good-faith estimate artifact was not recovered [PUBLIC https://www.cms.gov/initiatives/your-patient-rights/medical-bill-rights/get-help/guides-resources/what-good-faith-estimate]
Medical record access, transfer and retention Record custodian or privacy officer for each relevant entity Request verification, applicable deadline, export delivery, amendments, retention and legal hold, vendor copies, audio retention. HIPAA documentation must be retained at least 6 years. State medical-record retention varies by jurisdiction and entity; confirm it. Define S3 lifecycle for card images and lab PDFs and a post-sign-off audio policy No complete retention or custody workflow recovered [PUBLIC https://www.law.cornell.edu/cfr/text/45/164.530] [PUBLIC https://www.law.cornell.edu/cfr/text/45/164.524] [F:F8]
Clinical adverse event Licensed clinical lead Urgent triage, clinical documentation, care plan; separate reporting review Generic messaging and label routes observed; completed workflow not observed [PUBLIC Zepbound PI §17] [E:E16]
Dispensing and counseling Dispensing pharmacy Product acceptance, counseling, supplies, storage and replacement decision External channel instructions observed; GM acknowledgment feed unknown [PUBLIC https://www.gifthealth.com/faq-topics/prescriptions-getting-started] [D:D16]
Refund Billing or support owner Request, policy eligibility, original transaction, amount, execution reference, notice Visit and lab policies observed; execution system unverified [LIVE /refund-policy-labs] [C:C4.4]
Account closure or treatment stop Privacy, billing and clinical owners by distinct task Stop or transfer plan, future-order disposition, financial obligations, retention explanation Cancellation and decline actions do not establish all closures [E:E11] [INFERENCE: common practice]

4. Vendor and partner handoff register

The six evidence files contain 121 handoff rows. They collapse to 72 exchange entries below: one row per company or product per distinct data exchange and mechanism. A row marked * is on the cash path, including alternative pharmacy and lab channels. The register spans 32 cash-path entries, 72 total exchanges, and multiple products from single companies. A mandatory-party count for one journey is not established, and several rows are price feeds rather than prescription handoffs.

PHI column: Yes marks potentially identifiable health information, not an automatic BAA requirement. No means no patient identifier or clinical payload was observed. Unknown means the payload was not observable. Determine whether each recipient is a business associate, independent treating provider, payer or another legally permitted recipient. Privacy and legal own the disclosure basis and contract classification; BAA execution status remains unverified. [PUBLIC https://www.law.cornell.edu/cfr/text/45/164.502] [F:F8]

# Stage Counterparty (company / product) Direction Data exchanged Mechanism Trigger Who pays / fee PHI? Confidence Evidence
H01* A Google, Bing, DuckDuckGo organic search Inbound Query, referrer, landing URL, UA, IP HTTP referral Organic click None to GM; SEO cost No Observed [A:H1]
H02 A Google Ads Inbound gclid, gbraid, wbraid, landing URL URL query to 7-day cookie to CampaignTouch Paid click GM ad spend, unknown No Observed [A:H2]
H03 A Microsoft Advertising Inbound msclkid URL query to cookie Paid click GM ad spend, unknown No Observed [A:H3]
H04 A Meta Ads Inbound fbclid, _fbc, synthetic _fbp, in-app browser flag Cookie plus CampaignTouch, no pixel Paid social click GM ad spend, unknown No Observed [A:H4]
H05 A Kargo Inbound kad_cid URL query to cookie Mobile ad click GM ad spend, unknown No Observed [A:H5]
H06 A OpenAI ChatGPT Ads Inbound oppref URL query to cookie ChatGPT ad click GM ad spend, unknown No Observed [A:H6]
H07* A, B Segment, Twilio Outbound Page views, events, email, phone, click IDs, search queries, SKU and price context, tenant slug JS SDK to evs.segment.generalmedicine.co Every page and action GM subscription; BAA unknown Yes at signup Observed [A:H7] [B:H17]
H08* A, B Datadog RUM and Logs Outbound Session replay DOM and text, interactions, resources, errors, console logs, user id, flags, API latency Browser SDK Every page and action GM SaaS; BAA unknown Yes on clinical pages Observed [A:H8] [B:H18]
H09* A, B LaunchDarkly Outbound Context key, flag evaluations React SDK with useReport Every render GM SaaS No Observed [A:H9] [B:H20]
H10 A, B Google Analytics 4 Outbound Page location, referrer, client id, engagement gtag.js, G-9WGCRPWTXD Marketing page load Free No Observed [A:H10] [B:H19]
H11 A OneSignal Outbound Push player id, browser, site Web SDK v16 Marketing page load GM SaaS No Observed [A:H11]
H12 A Sanity Inbound Article and bio content, images CDN plus build or SSR CMS Page render GM SaaS No Observed [A:H12]
H13* A, B Google Maps Platform Both Address keystrokes, place ids, coordinates, ZIP, map viewport Maps JS, Places, Geocoding Address entry and compare drawer GM API usage Yes, address Observed [A:H13] [B:H6]
H14 A Vimeo Outbound Video requests, referrer, IP Progressive player Video play GM plan No Observed [A:H14]
H15* A Netlify, Vercel, CloudFront Both Request logs, IP, headers Hosting and CDN Every request GM hosting No Observed [A:H22]
H16 A, F Slack Nile-Core to Slack Session replay links and alerts Backend job to Slack webhook, dossier-attributed PDP, pharmacy or homepage view, deduped one per user per hour GM Slack plan Potential Direction observed; job name and dedupe dossier-attributed [A:H23] [F]
H17 A Trustpilot Outbound link None beyond the click Link User click None No Observed [A:H20]
H18 A, F LegitScript Outbound link None beyond the click, badge asset Link and badge User click Certification fee, unknown No Observed [A:H21] [F]
H19* A, E LillyDirect Pharmacy, price feed Inbound to GM Price, NCPDP 1574056, friendly id 88334 REST pharmacy_comparisons plus directory page Compare drawer or Lilly page Margin unknown No GM response observed; upstream supplier contact unverified [A:H15]
H20 A NovoCare, price feed Inbound to GM Price, NCPDP 5758074, friendly id 84293 REST Compare drawer Margin unknown No GM response observed; upstream supplier contact unverified [A:H16]
H21* A Retail chain price feed, CVS, Walgreens, Walmart, H-E-B, Randalls, Sam's Club Inbound to GM Chain, NCPDP, address, distance, total_price_cents REST Compare drawer Margin unknown No GM response observed; upstream supplier contact unverified [A:H17]
H22* A, D Amazon Pharmacy, price feed Inbound to GM Price, NCPDP 5919177 REST Compare drawer Margin unknown No GM response observed; upstream supplier contact unverified [A:H17] [D:H11]
H23* B, C, D, E Stripe Both SetupIntent, payment method, brand, last4, charge, 3DS, refund REST plus Stripe.js Card add, visit booking, pharmacy cash checkout Patient pays; GM processing fee Yes, payment metadata Observed [B:H21] [C:H1] [D:H9] [E:H10]
H24 B, C Persona Persona-related verification routes recovered; browser, vendor and backend transport unverified Government ID, selfie, name, DOB, inquiry result Routes and generic pre-visit requirement only; transport and GLP-1 activation unverified In-person verification and generic pre-visit requirement; GLP-1 trigger unknown GM per inquiry Yes Routes observed; transport and GLP-1 activation unverified [B:H22] [C:H13]
H25* B, C, E Twilio Programmable SMS and Verify Outbound Phone, 6-digit code, delivery result REST from a Cognito Lambda trigger OTP GM per message Yes, phone Observed [B:H1]
H26* B, C AWS Cognito Both Phone, OTP challenge and session, tokens, isExistingUser CUSTOM_AUTH behind /auth/* Every login and signup GM per MAU Yes Observed [B:H2]
H27 B Google Identity and OAuth Both Email, profile, OAuth state, token Redirect and REST Google button where enabled; not rendered on DTC Free Yes Observed [B:H3]
H28* B Verified, 1-Click Signup Both Phone plus DOB in; name, DOB, sex, email, addresses out REST via Nile-Core After OTP on DOB submit GM per lookup Yes Observed [B:H4]
H29 B Verified, 1-Click Health Both Name plus DOB to member id, payer, eligibility REST DOB submit or insurance step GM per lookup Yes Inferred [B:H5]
H30 B Email validation vendor, unnamed Both Email to isValid REST About-you submit when flag on GM per validation Yes Observed [B:H7]
H31 B, C Waystar Both X12 270 and 271: member, payer, service type to eligibility, copay, network, deductible EDI via connector Insurance onboarding GM transaction fee Yes Inferred [B:H8]
H32* B, C, D, E Payer and PBM eligibility Both Plan, network, copay, deductible, PA rules EDI 271 via clearinghouse Eligibility query Payer adjudicates Yes Observed request, inferred payload [B:H9] [C:H11] [D:H14]
H33 B Payer directory provider, unnamed Inbound to GM Payer list, payer ids GET /insurances/directory_payers Insurance search GM vendor fee, unknown No Observed [B:H10]
H34 B Card OCR provider, unnamed Both Card image ids to payer, member id, group, plan, then eligibility trigger_card_image_eligibility_check Patient photographs card GM per call Yes Inferred [B:H11]
H35 B, C, E AWS S3 Both Insurance card, external lab PDF, file ids, presigned URL Presigned PUT then complete Upload GM storage Yes Observed [B:H12] [C:H8] [E:H14]
H36* B, D, E Metriport Both Identity and consent to FHIR conditions, medications, allergies, procedures REST and FHIR HIE lookup, chart prewarm, AI prewarm GM per retrieval Yes Observed [B:H13] [D:H8] [E:H6]
H37* B, D, E Particle Health Both Same clinical domains, availability check REST Where Metriport lacks records GM per query Yes Observed [B:H14] [D:H8] [E:H6]
H38* B, C, D, E Emerald Medical Practice, P.C. and P.A. Both Identity, consents, HIE authorization, insurance assignment, clinical record, claims Click-through consent, assignment of benefits, claims Signup and every billed encounter Patient copay or cash; PC bills payer; GM MSO fee unknown Yes Observed [B:H15] [C:H10] [D:H1] [E:H1]
H39 D, E Ruby Medical Practice, P.C. and Centennial Medical Practice, P.C. Both Same as H38 Consent plus Visitron assignment Patient in NJ or ID Same as H38 Yes Observed [D:H2] [E:H1]
H40 B, D, E OpenLoop Healthcare Partners, Reliant.MD, MECNB under the Vital consent Both Telehealth consultation, consent, state entity, clinician credentials Network contract plus consent page If the visit routes to that network Network bills; GM coordinates Yes Inferred trigger [B:H16] [D:H3] [E:H2]
H41 C, F Trust Commerce Both guarantor_id, billing_ids, single-use token bound to visit and patient Hosted page plus callback Mercy tenant billing only Mercy patient Yes Inferred [C:H2]
H42* C, D, E Arrive Health Both Patient, drug, pharmacy to copay, deductible, formulary, PA signal, inquiry id REST and OAuth launch Pharmacy selection GM per transaction Yes Observed [C:H3] [D:H7] [E:H4]
H43* C, E, F Junction and Vital Both Patient, order, lab test ids, billing type, sample id, status, results, critical webhook, biomarker catalog REST and webhooks Lab order and result Test price plus clinical fee; split unknown Yes Observed [C:H5] [F]
H44* C, E Quest Diagnostics Both Requisition, accession and sample id, specimen, results, PDF LIS via Junction Draw Cash patient pays GM; insurance lab bills insurer Yes Observed [C:H6] [E:H13]
H45* C, E Labcorp Both Same as H44 LIS via Junction Draw Same as H44 Yes Observed [C:H6]
H46* C, E BioReference Both Same as H44 LIS via Junction Draw Same as H44 Yes Observed [C:H6]
H47* C Ordering physician, Junction-assigned or GM clinician Both Ordering provider name and NPI, critical-result call, interpretation and sign-off Junction network or Visitron Every lab order and every critical result $15 clinical review; split unknown Yes Observed role, inferred mode [C:H7]
H48 C MDSave Both mdsave price option, md_save agreement flag Offer in booking options In-person or urgent care only, not 300543 Patient pays voucher price Yes Observed absence on path [C:H12]
H49* D, E, F Athenahealth Both Encounter note, diagnoses, orders, care plan, athena_id REST sync and resync Clinician publishes or plan changes GM license Yes Observed [D:H4] [E:H5] [F]
H50* D, E, F DoseSpot Both Patient context, eligibility, formulary, draft and final Rx, EPCS identity, inbound refills SSO, REST, NCPDP SCRIPT Prescribe or renew GM license Yes Observed [D:H5] [E:H3] [F]
H51 D, E, F Nabla GM and clinician to Nabla audio and context; Nabla to GM draft and status Audio, transcript, note draft, status; transmitted content unverified Embedded scribe Clinician starts scribe GM license Yes Status operation observed; audio payload unverified [D:H6] [F]
H52* D, E LillyDirect Pharmacy, LLC, NCPDP 1574056, NPI 1912889320 GM to LillyDirect Rx, name, DOB, contact, NCPDP id, payment or insurance context eRx to NCPDP id, phone or fax fallback Patient selects LillyDirect Patient pays dispensing pharmacy; GM pay-ahead not available at mail order Yes Endpoint observed; downstream product route unverified [D:H10] [E:H7]
H53* D, E LillyDirect dispensing pharmacies, Amazon, Fuze Health, Gifthealth, Prescryptive, Walmart Pharmacy to patient Verification, checkout link, price, delivery or pickup, tracking, savings applied SMS, email, checkout Rx received Patient pays pharmacy Yes Destination set observed; product-level route unverified. Gifthealth publishes NCPDP 3692539 for its self-pay channel [D:H16] [PUBLIC https://www.gifthealth.com/faq-topics/prescriptions-getting-started]
H54* D, E Amazon Pharmacy, NCPDP 5919177, NPI 1285084467 GM to Amazon Rx, patient identifiers, payment context eRx to NCPDP id Patient selects Amazon Patient pays Amazon Yes Observed [D:H11] [E:H8]
H55 D, E NovoCare, NCPDP 5758074, NPI 1710671854 GM to NovoCare Rx and patient identifiers, for Wegovy eRx to NCPDP id Patient selects NovoCare Patient pays NovoCare Yes Observed [D:H12]
H56 D, E Retail pharmacy, CVS, Walgreens, Walmart, Costco, Safeway, Kroger, Rite Aid, Alto Both Rx, NCPDP id, demographics, prepaid notice or GM card, claim eRx plus NCPDP claim Patient selects retail Cash: patient pays GM or pharmacy; insured: PBM pays pharmacy and patient pays copay Yes Observed [D:H13] [E:H9]
H57 D, E PBM and payer claim adjudication Pharmacy to PBM Claim, member id, NDC, days supply, copay, PA NCPDP Telecommunication Fill PBM pays pharmacy Yes Inferred [D:H14]
H58* D, E, F Lilly and Novo savings programs, EVERSANA PTR Manufacturer to pharmacy and patient Savings card BIN and PCN, eligibility, PTR claim; offer version, payer eligibility, caps and actual redemption unverified Pharmacy claim plus manufacturer PTR at eversana-ptr.virtualrx.co Eligible fill Manufacturer funds; patient pays reduced copay Yes Program terms published; GM eligibility and redemption unverified [D:H15] [PUBLIC https://zepbound.lilly.com/savings]
H59 D, E Retail or LillyDirect pharmacy to GM Inbound Refill request, Rx status, rejection, PA request eRx inbound, fax, phone, message subject pharmacy_order Refill or claim issue No direct fee Yes Observed [D:H17]
H60 D, E GM operations to payer, PA submission Outbound PA form, chart evidence, letter of medical necessity, appeal; lifecycle in §3.8 Unknown: portal, fax, or phone; no ePA evidenced PA required or denied GM staff time Yes Inferred; channel unknown [D:H18]
H61* D, E, F Zoom Outbound Unique meeting URL, meeting id, passcode Link by SMS and email Video visit booked GM pays Zoom Yes Observed [D] [E:H12]
H62 E Twilio Conversations and SMS short code 98528 Both Chat token, messages, attachments, SMS JWT plus REST Patient messages or receives reminder GM per message Yes Observed [E:H11]
H63* E Email provider, unidentified Outbound Visit link, lab notice, prescription notice, care plan Email API or SMTP Events GM vendor Yes Observed channel, vendor unknown [E:H15]
H64 E Braintrust Outbound AI span score, thumbs category and comment /api/chat/feedback Patient rates an AI answer GM Potential Observed [E:H16]
H65 E, F Databricks and Metabase Internal Warehouse tables to dashboards Metabase Databricks driver Analyst query Unknown Potential Observed [E:H17] [F]
H66* E Eli Lilly, IFU and Medication Guide, MedWatch Lilly to patient labeling; patient or clinician to Lilly or FDA safety report Instructions for use, adverse-event and product-complaint report Paper insert, LillyDirect, 1-800-LillyRx, FDA MedWatch First fill, side effect or product complaint Patient pays drug and needles Yes for the report; No for the label Observed routes; GM reporting practice unknown [E:H18] [PUBLIC Zepbound PI §17]
H67 E, F Zendesk Internal Async chat and triage threads, clinician replies, attachments Agent workspace Chat visit or triage message Subscription Yes Observed [F]
H68 F Ashby Both 16 requisitions, applications Hosted job board and API Recruiting Plan No Observed [F]
H69 D, F CMS NPPES and NPI Registry Outbound query NPI, legal name, address, taxonomy Public API Entity verification None No Observed [D:source appendix]
H70 F CMS Medicare Part D and GLP-1 Bridge Payer program Part D enrollment, bridge eligibility, covered product and presentation, PA. The bridge is time-limited and names Zepbound KwikPen; do not generalize to all tirzepatide or all Medicare patients Program rules, no GM API observed Medicare patient Medicare pays; eligible bridge patient at most $50 per month Yes Published terms; GM integration not observed [PUBLIC https://www.medicare.gov/coverage/weight-loss-drugs] [D:D4.4]
H71 E LLM provider, vendor unknown, via Promptimus and copilot Outbound Prompt context, health records, messages, care-plan draft API AI draft or patient chat GM contract unknown Yes Inferred [F:F3.3]
H72 F Google OAuth and AWS Cognito, staff plane Both Staff identity, extension token OAuth code flow, /api/internal_oauth Admin login Unknown No Observed [F]

5. Integration sequence diagrams

5.1 Sign-up and identity

DatadogSegmentVerifiedTwilioAWS CognitoNile-CoreStorefrontPatientDatadogSegmentVerifiedTwilioAWS CognitoNile-CoreStorefrontPatientalt[Match found][No match ortimeout]opt[SignupTracker mounts, fetchUser succeeds, analytics available]Enter US mobile number1POST /auth/initiate2CUSTOM_AUTH challenge3Send 6-digit OTP4SMS code5Enter code6POST /auth/login7Verify session8HttpOnly session cookie9Enter date of birth10POST /api/external/verified11Phone and DOB lookup12Name, sex, email, addresses13Autofill profile14Confirm autofilled details15Manual about-you form, noerror shown16Accept six consents andcontinue17POST /api/external/patients18Patient id, signup channel. HIEnotice is not returned by the API19Redirect to /welcome or/ai/onboarding20signup_complete and identify with email and phone21alias with user id only22RUM session and replay23

Note: the Segment calls are guarded and were not observed on the GLP-1 redirect path. signup_complete and identify carry email and phone; alias carries only the user ID. The HIE notice and PDF opt-out were observed on the manual about-you form only, not on the Verified review-info path.

5.2 Insurance eligibility

S3PayerClearinghouseEligibility serviceNile-CoreInsurance screenPatientS3PayerClearinghouseEligibility serviceNile-CoreInsurance screenPatientopt[Card photo]opt[Discovery is used]alt[Response received][Pending, timeout or error]alt[In network][Not found, out ofnetwork orunknown]Choose payer or photographcard1Presigned PUT of front and back images2trigger_card_image_eligibility_c-heck3enqueue_eligibility_check4Name and DOB discovery5Member id and payer, or nomatch6X12 270 eligibility7270 inquiry8271 response9Copay, network, deductible10insurance_status11No usable response12Pending or unknown13Show 25 dollar estimate14Offer retry or continuewithout insurance at 100dollars15

Note: illustrative backend flow. The discovery vendor, clearinghouse protocol and payer response were not observed for this journey.

5.3 Visit, prescription, and pharmacy, cash LillyDirect and insured retail

StripePayer PBMRetail pharmacyDispensingpharmacyLillyDirectMetriportAthenahealthArrive HealthDoseSpotVisitronStorefrontPatientStripePayer PBMRetail pharmacyDispensingpharmacyLillyDirectMetriportAthenahealthArrive HealthDoseSpotVisitronStorefrontPatientNo PA case contract recovered, several business daysalt[PA required][Paid]alt[Cash LillyDirect][Insured retail]Book and pay visit fee1SetupIntent or charge2Create appointment3Prewarm chart and prior records4RTPB and formulary inquiry5Coverage and PA signal6Benefit inquiry with drug and pharmacy7Copay, formulary, PA signal8Finalize Rx9Sync signed encounter and care plan10Care plan and prescriptioncard11Open pharmacy order andchoose pharmacy12RTPB for selected pharmacy13eRx to NCPDP 157405614Route to dispensingpharmacy15Checkout link and delivery options16Pay dispensing pharmacy17Ship 1 to 4 days18eRx to selected NCPDP id19Submit claim20Reject for PA21PA notice and wait22Paid claim23Dispense or pickup notice24

Note: the cash branch pays the dispensing pharmacy once. Mail order is excluded from GM pay-ahead. 1574056 is GM's observed LillyDirect row; product-level routing may differ.

5.4 Baseline labs via Junction

OrderingphysicianClinicianQuest or Labcorpor BioReferenceJunction VitalNile-CoreStorefrontPatientOrderingphysicianClinicianQuest or Labcorpor BioReferenceJunction VitalNile-CoreStorefrontPatientOrder may be pre-start or post-start, and does not gate every first fillCritical call does not wait for routine review, acknowledgment is unverifiedopt[Critical value]alt[Result abnormal][Result normal]Buy panel 503263 and choosenetwork1Create lab order and charge86.582Lab order with patient andtest ids3Requisition and order4Walk-in or scheduled draw5Specimen, accession, result6Result payload7Immediate phone call to ordering physician8Result in Updates and chart9Clinical outreach and next step10Dashboard card and PDF11

Note: lab ordering and pharmacy fulfillment are separate flows. If the clinician requires pre-start labs, the pharmacy order waits for result review; otherwise it does not.

5.5 Week-4 check-in and phase change to 5 mg

Payer PBMPharmacyDoseSpotClinicianVisitronNile-CoreStorefrontPatientPayer PBMPharmacyDoseSpotClinicianVisitronNile-CoreStorefrontPatientProposed target: start refill work T+14 to T+18 and backward-plan from T+28. GM trigger unverifiedalt[PA required for new strength][Paid]alt[Cash][Insured]Complete check-inquestionnaire and optionallabs1Submit criteria responses2Unlock pending review3Present check-in, labs, and AIdraft4Apply review and changephase to 5 mg5New Rx for 5 mg6Open new pharmacy order7Select pharmacy8Transmit eRx for 5 mg9Pay pharmacy at checkout10Dispense second box11Claim for 5 mg12Reject for PA13Delay, new PA needed14Paid claim15Dispense second box16

Note: cash does not route through the PBM. A same-strength refill may already have refills available; a new strength requires an appropriate new prescription.


6. Data, states and events

6.1 Core objects

Object Key fields Owner States observed Authority Evidence
Patient id, name, DOB, sex at birth, phone, email, address, consents, attribution, signup_id, signup_sku_id, signup_channel Nile-Core anonymous, authenticated, patient record, blocked, closed API fields observed; account lifecycle partly inferred [B:B7] [E:E16]
SKU id, category, state, allows_video_visit, allows_chat, allows_econsult, allows_first_fill, allows_refill, allows_referral, indexable, page_content, component_order Catalog enabled, dark_launched, disabled; pathways draft, published, archived Catalog operation inventory [F:F1] [F:F0.1]
SKU option modality, cash price, insurance price, primary, availability promise Catalog video, chat, econsult, in-person; cash or insurance sub-option Live API payload [A:A5.1]
Questionnaire screening id, history id, question order, questionnaire_length, version, edit approval Catalog draft, edit requested, applied, published Catalog operations; content unrecovered [F:F2]
Question response questionnaire id, question id, answer, read state Nile-Core unanswered, answered, read API fields [B:B11]
Visit id, SKU, modality, clinician, scheduled_time, state, meeting_url, billing type, price Nile-Core The client UI classifier maps booked, scheduled, confirmed, awaiting_confirmation, ready_for_visit, held, in_progress, canceled, hold_expired, patient_no_show, plus other care-action strings UI classifier; server enum and transitions unverified [CODE components/CareActions/careActionSection.ts:40-89]
Care::Plan care_id, plan_id, state, next steps, patient_instructions, patient_rationale Visitron The UI classifier maps six preparation strings under care plans: awaiting_curation, awaiting_external_work, awaiting_generation, in_review, awaiting_first_send, awaiting_curation_send. sent is a shared terminal state, not exclusively a plan state UI classifier only; server enum and transition order unverified [E:E1] [CODE components/CareActions/careActionSection.ts:64-78]
CarePathway and phase pathway_id, ordered phases, phase_id, modality, linked SKUs Catalog draft, published, archived Catalog operation inventory [E:E1.2]
CareJourney criteria type Lab, Questionnaire, or Visit; status, locked, available_at, deadline, estimated_minutes, lab bundle metadata Server-side criteria set locked, available, completed Generic criteria API; GLP-1 set unrecovered [E:E1.2] [E:E6]
NextStep and NextStepCard kind, deadline, assigned_by, snooze, dismiss, due_date, open_to_renew Nile-Core open, snoozed, dismissed, completed API fields; eight card kinds observed [E:E5] [E:E9]
NextStepReview proposed_json, final_json, decision, rationale Visitron draft, applied, rejected, confirmed Operation names recovered; field names dossier-attributed, not first-party contracts [F:F3.3]
Prescription id, drug, strength, form, quantity, days supply, refills, SIG, pharmacy NCPDP id DoseSpot and Nile-Core draft, finalized, transmitted, renewal required Visitron and DoseSpot operations [D:D8]
PharmacyOrder id, medication_option_sku_id, NCPDP id, billing_type, cash and insurance price, state, cancel and switch flags Nile-Core client exposes a state string plus cancel and switch flags; four-state sequence is a dossier hypothesis Cancellation response fields; authoritative enum unverified [D:D11-D15] [E:E1.3]
LabOrder id, SKUs, network, accession_number, scheduled_at, lab_vendor_name, clinical_fee, result status Nile-Core and Junction received, collecting_sample, sample_with_lab, completed API and data model; authoritative enum unverified [C:C19-C21]
Insurance policy payer, member id, group, network status, copay, onboarding state Nile-Core discovered, queued, checked, activated, failed Context and API fields [B:B9]
Conversation id, subject category (visit, lab, pharmacy_order), response_expectation, messages, attachments Nile-Core and Twilio open, unread, read, closed API fields [E:E3]
Payment method id, brand, last4, expiry, default flag, Stripe token Stripe active, deleted, default Stripe fields [C:C4.7]

6.2 State machines that matter

Pharmacy order. The four-state sequence created → pharmacy_selected → order_placed → dispensed is a dossier hypothesis, not an observed authoritative state machine. The inspected client exposes a state string plus can_cancel_pharmacy_order, can_switch_pharmacy, and can_choose_new_pharmacy in a cancellation response. No acknowledgment, rejection, dispense or tracking field was recovered; a server-side feed may exist outside the inspected surfaces. [D:D5.4] [E:E7]

Care plan and next-step review. These are separate objects. The UI classifier contains six care-plan preparation strings plus sent as a shared terminal state. Their membership in a server Care::Plan enum and the transition order are unverified. Visitron exposes review-generation, edit, apply, confirm and reject operations. The proposed_json and final_json field names are dossier-attributed, not recovered first-party contracts. [E:E1] [F:F3.3] [CODE components/CareActions/careActionSection.ts:64-78]

Care journey. Criteria are typed Lab, Questionnaire, or Visit, with locked, available_at, deadline, and status. The recovered API is generic and handles feature-disabled 404s. The GLP-1-specific schedule, blocking rule and exceptions are server-side and were not recovered. [E:E1.2]

Visit. The client UI classifier contains visit-related state strings, including held and hold_expired, plus terminal canceled and patient_no_show. Fee-eligible visit types are video only. The server enum, count and transition rules are unverified. [CODE components/CareActions/careActionSection.ts:40-89]

SKU and pathway. SKUs use enabled and dark_launched; pathways use draft, published, archived. A launch is a Catalog content operation, not a deploy. [F:F0.1]

6.3 Analytics events observed

Group Events Properties worth noting Evidence
Landing page, landing_page_loaded, landing_page_frames_dwell, ad_landing_page_view path, URL, title, referrer, search, tenant_slug, sku_id, TTFB, DCL, LCP, cache hit, auth flag, frame dwell [A:A2]
Storefront sf_viewed_detail_page, new_storefront_pdp_viewed, sf_clicked_sku, sku_page_cta_clicked, new_storefront_request_medication_clicked, sku_page_variant, sku_sticky_cta_variant SKU object with price, variant, button type, latency timer [A:A4]
Search sf_search_start, sf_search_query, sf_submitted_search, sf_viewed_search_results, sf_viewed_search_results_failure Raw query and full suggestion array, result count and ids [A:A11]
Signup signup_page_viewed, signup_referrer, signup_step_phone, signup_step_otp, otp_send_requested, otp_completed, otp_first_digit_entered, otp_resend_requested, otp_submit_attempted, otp_verified, otp_screen_abandoned, signup_complete, merge_identity Email and phone in both signup_complete and identify; click ids; signup_channel; OTP telemetry excludes phone and code by rule [A:A7] [B:B2] [CODE components/SignupTracker.tsx:16-98]
Checkout visit_id, sku_id, billing_type, insurance_status, price_cents, cancellation_fee_shown, within_24_hours, agreement flags, price_guaranteed, price_fallback Funnel render and click events [C:C8]
Care ns_ namespace, 17 events; PATIENT_RATIONALE_VIEWED, PATIENT_RATIONALE_FEEDBACK, dashboard 1.0 and 1.5 event sets Next steps, rationale, dashboard version [F:F4.1]
Insurance ssi_ namespace; booking_no_medicaid_option, booking_no_availability Payer, network, plan category [F:F6]
Experiments EMAIL_VALIDATION_VARIANT, SKU_PAGE_VARIANT, SKU_STICKY_CTA_VARIANT Flag key, anonymous id, Datadog session id [F:F4]
Errors client_error; Datadog nile-core-api-request Method, normalized path, status, latency [A:A3.1] [F:F4.1]

Two gaps matter. No event was observed for a pharmacy dispense, a dose taken, a weight measurement, or a PA outcome; production may track these outside the inspected surfaces. And signup_complete and identify both carry email and phone, but both are guarded by tracker mount, fetchUser, analytics availability and a local flag, so firing on the Lilly and GLP-1 CTA path was not observed. [A:A8] [CODE components/SignupTracker.tsx:16-98]

6.4 Where PHI flows

BAA status is unknown for every vendor flow because no BAA inventory was observed.

Flow What leaves Recipient BAA status Risk Evidence
Browser to Segment Email, phone, GLP-1 SKU and condition context, raw search queries, click ids Segment, then unknown destinations Unknown High: re-identification plus health interest [A:H7] [B:H17] [A:A3.4]
Browser to Datadog Recovered replay configuration would capture DOM text, interactions, resources and errors; an explicit phone masking marker was found. Other component rules and effective runtime masking remain unverified; capture of specific GLP-1 questionnaire answers, retention and destination access were not verified Datadog Unknown High-priority privacy review; asserted answer capture is not established [A:H8] [A:A3.4] [CODE components/Inputs/PhoneInput.tsx:158]
Browser to Google Maps Home address keystrokes, coordinates Google Unknown Medium [B:H6] [A:H13]
Browser to Verified Browser sends phone and DOB to GM; GM then calls Verified. A direct browser-to-Verified call was not observed Verified Vendor claims HIPAA, no BAA observed High [B:H4] [B:H5]
Browser to S3 Insurance card images, external lab PDFs AWS Unknown High [B:H12] [C:H8]
Nile-Core to Waystar and payer Eligibility request and response; exact X12 270/271 payload unverified Waystar, payer Unknown High [B:H8] [B:H9]
Nile-Core to Metriport and Particle Identity, consent, FHIR conditions, meds, allergies, procedures HIE vendors Unknown High [B:H13] [B:H14]
Nile-Core to Slack Session replay links to #session-replay-new-storefront Slack Unknown Medium: link access [A:H23]
Nile-Core to Databricks and Metabase Product and clinical events, dashboards Internal BI Internal use; the Metabase login shell is publicly reachable and the reviewed response requires sign-in Medium: network exposure; unauthenticated data access not established [E:H17] [F:F4.1]
Visitron to Athena and DoseSpot Encounter, diagnoses, orders and prescriptions; exact payloads unverified EHR, eRx Unknown High [D:H4] [D:H5]
Nabla integration Status operation recovered; audio/context submission and returned transcript or draft are attributed workflow, not observed payloads. Direction, content and retention require verification Scribe Unknown High [D:H6] [F]
GM to Arrive Health Patient, drug, pharmacy, benefit context Arrive Unknown High [D:H7] [E:H4]
Patient to Twilio and Zendesk Phone, SMS and chat content, attachments Twilio, Zendesk Unknown High [E:H11] [F]
GM to LLM provider Prompt context, health records, messages Vendor unknown Unknown High [F:F3.3] [E:H16]
GM to pharmacy and lab Prescription, demographics, order, results Pharmacies, labs Determine each recipient's role: independent treating provider or business associate. HIPAA minimum necessary does not apply to provider treatment disclosures; assess BAA and data minimization by relationship Medium: role and contract dependent [D:H10-H13] [C:H6] [PUBLIC https://www.law.cornell.edu/cfr/text/45/164.502]
GM to email provider Visit links, lab-result notices, prescription notices Vendor unknown Unknown Medium [E:H15]

The privacy notice says PHI is handled under BAAs "that General has in place with Emerald Providers" and discloses business associates for technology, transcription, billing, and collection. No subprocessor list or BAA text was found. [F:F8]


7. Money map

7.1 Who pays whom

Capture timing is inferred for visit fees. The checkout shows "Due Today", the cancellation policy says already-paid fees are refunded automatically, and the assignment of benefits allows an up-front estimate, but no charge object or auth-then-capture call was recovered. [C:C4.1]

Path Payer Payee When Amount Basis
Cash visit Patient GM via Stripe At booking $100 video, $30 chat [C:C4.1]
Insured visit Patient GM or PC at booking At booking, estimate $25 estimated copay [C:C4.1]
Insured visit claim Payer PC After claim Unknown, contract rate [B:B15]
Clinician labor GM 1099 clinician Per completed visit $50 video or $12 chat for MD; $35 or $8 for NP [F:F3.4]
Lab, cash Patient GM via Stripe At lab checkout Test price plus $15.00 [C:C4.3]
Lab, wholesale GM Lab through Junction Per order Unknown [C:C4]
Lab, insured Payer Lab After claim Unknown; insurance_price null [C:C4.3]
Drug, cash pre-pay at retail Patient GM via Stripe At pharmacy checkout Sampled retail $496.12 to $508.09 for the starter KwikPen; $299 is the direct-mail price. Pay-ahead only if offered for the selected pharmacy [D:D4.3] [LIVE /api/external/pharmacy_comparisons]
Drug, retail counter with GM card Patient Pharmacy At pickup Discounted cash price [D:D4.3]
Drug, mail order Patient LillyDirect dispensing pharmacy or Amazon At pharmacy checkout link $299, $399, or $449 [D:D4.3]
Drug, insured Payer Pharmacy Claim Contract rate; patient copay [D:D4.3]
Manufacturer savings Lilly or Novo Pharmacy or patient At adjudication Reduces patient copay [D:D4.4]
Cancellation fee Patient GM Within 24 hours or no-show $25 fallback, video only [C:C4.4]
Refund, visit GM Patient After eligible cancellation Visit fee, 5 to 10 business days [C:C4.4]
Refund, lab GM Patient Request within 6 months of purchase if sample not collected Full amount, no deduction; collection ends eligibility [LIVE /refund-policy-labs]
Pharmacy routing Unknown Unknown Per fill No fee or spread field observed [D:D4.6]

7.2 Illustrative cash outlay through purchase of the second fill

Assumes a video visit at E0, one Quest Comprehensive GLP-1 panel, the 2.5 mg KwikPen at LillyDirect or Amazon, a week-4 video follow-up, and the 5 mg KwikPen. This is two 28-day drug purchases, not one month of medicine.

Line Amount Evidence
Initial visit plus first 28-day supply $399.00 $100 visit + $299 2.5 mg. [LIVE /api/external/sku_options/300543] [LIVE /api/external/medication_option_skus/710641/cash_price]
Initial visit, first supply and Quest panel $485.58 Add $86.58. [LIVE /api/external/lab_skus/503263]
GLP-1 evaluation, video cash $100.00 [LIVE /api/external/sku_options/300543]
Comprehensive GLP-1 panel, Quest cash $86.58 [LIVE /api/external/lab_skus/503263]
Zepbound KwikPen 2.5 mg, 28 days $299.00 [LIVE /api/external/medication_option_skus/710641/cash_price]
Week-4 follow-up, video cash $100.00 [LIVE /api/external/sku_options/300550]
Zepbound KwikPen 5 mg, 28 days $399.00 [LIVE /api/external/medication_option_skus/710643/cash_price]
Two-fill total $984.58 Arithmetic on observed prices; calendar timing depends on the journey
Same two-fill scenario without panel $898.00 [E:E4.5]
Same two-fill scenario with chat visits $844.58 $30 plus $30 visits
Default auto-injector instead of KwikPen $2,434.76 to $2,486.90 $1,074.09 or $1,100.16 twice, plus visits and panel; assumes the same unit price on both fills. Re-quote the 5 mg SKU
Retail cash instead of direct $1,278.82 to $1,302.76 $496.12 or $508.09 twice, plus visits and panel; same assumption

7.3 Illustrative insured non-drug subtotal

Assumes a commercial plan, in-network video visits at day 0 and week 4, one lab order, and a covered drug after PA. The medication check-in itself may not require a paid visit. Medication copay and lab deductible, coinsurance or uncovered charges are not observable before adjudication.

Line Amount Evidence
GLP-1 evaluation, video insured $25.00 estimated [LIVE /api/external/sku_options/300543]
Week-4 follow-up, video insured, if booked $25.00 estimated [LIVE /api/external/sku_options/300550]
Lab clinical review fee $15.00, not covered by insurance [CODE components/Labs/AboutLabPricing.tsx:42-45]
Drug liability for both fills Unknown; insurance.price is null on every GLP-1 medication SKU [LIVE medication_option_skus]
Lab deductible, coinsurance or uncovered charges Unknown; insurance_price is null [LIVE /api/external/lab_skus/503263]
Estimated non-drug subtotal, no paid week-4 visit $40.00 plus both fills and lab liability $25 initial visit + $15 lab review; async check-in assumed. Arithmetic on estimates
Estimated non-drug subtotal, paid week-4 visit $65.00 plus both fills and lab liability Add $25 follow-up. Arithmetic on estimates; final total unknown
If PA is denied and the patient pays cash Add $299.00 and $399.00 [D:D5.2]
If covered commercial and the single-dose pen card applies As little as $25 per eligible 1-, 2- or 3-month fill, not per month. Caps $100/$200/$300 for those fills, $1,300 per calendar year, up to 13 fills. Card expires 2026-12-31 [PUBLIC https://zepbound.lilly.com/savings/terms-and-conditions]
If not covered and the single-dose pen card applies As low as $499 per month for not-covered commercial single-dose pen, subject to current terms [PUBLIC https://zepbound.lilly.com/savings/terms-and-conditions]
Eligibility boundaries Government beneficiaries including Medicare, Medicaid, TRICARE and VA are excluded from commercial cards. The prescription must be for an approved use consistent with labeling; off-label use is not an approved use. Secondary claim and actual redemption are not observed [PUBLIC https://zepbound.lilly.com/savings/terms-and-conditions] [PUBLIC Zepbound PI §1]

Note: the KwikPen self-pay ladder is cash-only and excludes insurance reimbursement. A patient cannot combine the $299 KwikPen price with a commercial claim. The insured path and the cash path are mutually exclusive at the fill. [PUBLIC https://zepbound.lilly.com/savings]

7.4 GM revenue lines versus pass-through

Line Observed amount Treatment Evidence
Visit fee $100 cash or $25 insured estimate GM or PC revenue; clinician fee is a variable cost [C:C4.1] [F:F3.4]
Clinician labor $50 or $35 video, $12 or $8 chat Variable cost, not revenue [F:F3.4]
Lab clinical review fee $15.00 per order Revenue; split with ordering physician unknown [C:C4.3]
Lab test price $71.58 Quest for 503263 Pass-through or spread; wholesale cost unknown [C:C4.3]
Platform, order, collection fees $15.00 to $40.00 platform, $6.00 order, $3.00 to $9.00 collection. Panel 503263 returns $40.00 platform, $6.00 order and $9.00 Quest collection Returned by API but outside total_cash_price; accounting treatment and whether any is charged are unknown. Do not book as margin or add as a patient charge without settlement evidence [F:F5.2] [LIVE /api/external/lab_skus/503263]
Drug price $299, $399, $449 Manufacturer self-pay price; no GM margin field or contract observed [D:D4.2] [D:D4.6]
Pharmacy routing and GM card No fee field Economics unknown [D:D4.6]
Enterprise licensing Not disclosed Walmart Better Care Services, Mercy white-label [F:F5.3]

The unit-economics read. These are illustrative encounter contributions before other direct costs, assuming the posted contractor fee and full collection. They are not observed GM gross margin, recognized revenue or current provider mix. A cash video visit contributes about $50 with an MD or $65 with an NP before overhead. An insured $25 video visit is negative $25 with an MD and negative $10 with an NP before any payer claim. Chat is the best contribution per clinician dollar: $18 with an MD, $22 with an NP on a $30 cash chat. The employed model implies about $46 to $51 of physician labor per visit at full density. [INFERENCE from observed prices and posted fees] [F:F5.3.1]

Note: evidence-F §5.3.1 models a $25 insured chat row, but the live GLP-1 SKUs offer chat as $30 cash only, with no insurance sub-option. Do not use an insured-chat contribution for this path. [D:D0.3] [LIVE /api/external/sku_options/300543]


8. Operating model

8.1 Roles

Role Entity Tool or queue What they do on this path Observed pay and hours Evidence
Full-time physician GM clinical Athena, Zoom, Zendesk, Slack, Nabla, Visitron 20-minute video visits, async chat, prescribing, care-plan sign-off $180k to $200k plus equity and malpractice; 36 clinical hours per week; DEA required [F:F3.1] [F:F3.4]
1099 physician GM panel Same plus Visitron Video and chat visits alongside another practice $50 per video, $12 per chat; 10 to 12 hours per week; multistate licensure 20 to 30 percent of US population [F:F3.4]
1099 nurse practitioner GM panel Same Video and chat visits under collaborative agreements where required $35 per video, $8 per chat; 12 to 15 hours per week; licensure at least 30 percent of US population [F:F3.4]
Medical Director Emerald PCs Visitron, Provider Chat Clinical oversight, protocol approval, guide review, prompt tuning Not posted [D:D3]
Clinical operations lead GM Cross-portal Builds clinical teams, policies, partnerships Not posted [F:F3.1]
Clinician training lead GM Training program Trains every new clinician before first patient Not posted [F:F3.1]
Care coordinator GM operations Athena, phone, Referrals Scheduling, reminders, calls to patients, provider offices, insurers, labs; referral and authorization paperwork $22 per hour, full-time, remote [F:F3.1]
Operations Manager and Director GM operations Referrals plus internal tools Line management, referral and scheduling operations Not posted [F:F3.1]
Manager, NP licensure and collaborative practice GM State boards, no internal portal Maintains CPA templates, collaborating-physician bench, primary-source verification, state filings, pharmacy refusal escalations Not posted [F:F3.1]
Catalog operator GM clinical product Catalog, 106 operations Authors SKUs, phases, criteria, questionnaires, lab panels, codes, prompts Not posted [F:F0.1]
Prompt engineer and medical director GM Provider Chat, Promptimus, Visitron test harness Tests prompts, models, temperature; reviews thumbs-down clusters Not posted [F:F3.3]
RCM Director and VP GM finance Waystar, payer portals Patient access, authorization, coding, billing, denials, collections, payer contracts Not posted; authorization explicitly in scope [F:F3.1]
Support agent GM SMS 98528, Message Center, phones (801) 251-6055 and (801) 255-6051, emails help@generalmedicine.co, hello@generalmedicine.co, support@navhealth.co Refunds, cancellations, pharmacy and lab questions Not posted; Mon to Fri 9 to 9 ET, a 12-hour window. Individual clinician shifts are 4 to 6 hours inside it [C:C3] [F:F3.2] [E:E3]
Pharmacist Partner pharmacy Pharmacy system Verify, adjudicate, counsel, dispense, collect Not posted [D:D3]
Engineering on-call GM Datadog, Visitron, Nile-Core Integration outages, stuck encounters, eRx failures Not posted [D:D3]

Clinicians are contracted or employed by the state PCs or the delegated network and scheduled through Visitron; the MSO employs non-clinical staff and runs the platform. The state-to-PC assignment is server-side and unresolved. [F:F8] [D:D3]

8.2 Queues, tools, SLAs, hours

Queue Object Assignment Observed SLA or timing Evidence
Visitron appointment list Appointment Clinician sees own schedule; no claim primitive Video promise "today"; chat next slot timestamp [F:F3.2]
Video capacity Visit Scheduled block 20 minutes per visit, max 9 per 4-hour block, 36 clinical hours per week [F:F3.2]
Chat and triage Chat visit Zendesk queue 3-hour response window [F:F3.2]
Draft encounter Encounter Clinician owns it No SLA [F:F3.2]
Async clinical review Clinician review Pulled from pending list Not enabled on the GLP-1 SKU; no SLA. Whether a case is routed manually is unknown [F:F3.2]
Care-plan generation Care::Plan Clinician review of AI draft No system SLA [F:F3.2]
Care Journey criteria Patient action Patient-owned, clinician advances phase Server-side deadlines only [F:F3.2]
Referrals promises In-person referral Atomic claim, snooze, drop Not on the GLP-1 path; allows_referral:false [F:F6]
Pharmacy order PharmacyOrder Patient-driven No dispense or ack state recovered in the inspected client [F:F3.2]
Message Center Conversation Care team by subject Server-computed per thread; support Mon to Fri 9 to 9 ET [F:F3.2]
Clinician shift Shift Clock-out checkout 4 to 6 hour blocks, Mon to Fri 7 a.m. to 7 p.m. MT [F:F3.2]
Lab result review LabOrder Clinician or care team 48-hour result claim; critical call immediate [C:C21] [C:C5]
PA work No PA case object recovered in inspected interfaces RCM and care team Several business days, no measured p50 or p90; production queue unknown [D:D5.2]
Refund execution No endpoint Support, outside recovered tooling Visit 5 to 10 business days; lab up to 6 months [C:C3]

8.3 RACI by activity

R is responsible, A is accountable, C is consulted, I is informed. Every row has exactly one internal accountable role. External pharmacies, labs and payers are counterparties, not accountable owners. This is a proposed operating model, not an observed one.

Activity Patient Eng and Product Catalog and Growth Prescribing clinician Medical Director NP Licensure Care Coord and PA Support RCM Privacy and Compliance
SEO, sitemaps, default SKU, price copy I R A I C I I I I I
Privacy boundary, replay, Segment PII, BAAs I R C I I I I I I A
Signup, OTP, identity fallback, duplicate charts R A I C I I I R I C
Eligibility, card OCR, self-pay estimate C C I I I I R I A C
State-to-PC routing, license and CPA checks I C I C C A, R I I I I
Screening red flag and acute triage I C C R A I C I I C
Visit, indication, medication reconciliation, counseling C I I A, R C I I I I I
eRx signing, presentation, quantity, supplies I C I A, R I I I I I I
Labs, abnormal and critical result loop R C I A, R C I R I I I
Pharmacy selection, eRx ack, stockout reroute R C I C I I A, R C I I
PA submission, RFI, appeal, claim re-adjudication I C I C I I R I A I
Possession, cold chain, Dose-1 training R C I C A I R C I I
Weeks 1 to 3 side effects and safety report I C I R A I C I I C
T+14 to T+18 refill start and T+28 continuity R C I A, R C I R I I I
Refunds and cancellation waiver I C I I I I I R A C
Records access, export and retention I C I I I I I R I A

8.4 Staffing: known versus unknown

Known: - About 104 employees, three hubs, 16 open roles: 4 clinical, 2 operations, 4 engineering, 3 product, 3 finance. [F:F9] - 1099 clinician pay and hours; care coordinator at $22 per hour; FT physician at $180k to $200k for 36 clinical hours. [F:F3.4] - 20 public clinician bios. [F:F9]

Unknown: - Headcount for care coordination, support, RCM, and pharmacy or PA. No pharmacy technician, prior-auth specialist, or benefits-verification role appears among the 16 open requisitions. [F:F9] - Queue depths, arrival rates, and p50 or p90 turnaround for any queue. - After-hours clinical coverage. The only emergency instruction is 911; no nurse line or on-call clinician pager was observed. [E:E16] - Whether Zendesk also backs patient support agents or only clinician chat. [F:F3.2] - BAA inventory and subprocessor list. [F:F8]


9. Failure modes and branches

Trigger Patient impact Current handling observed Gap Recommended control Evidence
Commercial head terms do not rank Patient never finds GM None SEO architecture sends crawlers to noindex /s/ URLs Fix canonical, sitemap, and internal links to /dp/ [A:A2.2]
/weight-loss short URL Patient hits a login wall 307 to /login Not in sitemap or internal links Redirect to /store/weight-loss or /get-started [A:A8]
Default Zepbound SKU is the auto-injector Price shock at $1,074.09 versus $299 Family default and Lilly CTA point at the expensive form; production intent unverified Price and default mismatch Default to KwikPen or show a form comparison with prices [A:A5.1] [D:D0.3]
Vial SKU selected No price, no direct channel Shows "-" and "priced after visit" Null cash price, no LillyDirect row Hide or price the vial path [A:A5.2] [D:D0.3]
Public catalog does not quote insured drug cost Drop-off at the visit fee "Available after visit" tooltip; RTPB may estimate after prescribing No pre-visit patient-specific estimate Show a range and explain that the adjudicated claim sets the payable amount [A:A5.2] [CODE components/ProductDetailPage/MedicationPriceCard.tsx:12-20]
OTP not delivered Signup blocked Resend, support short code No voice or email fallback observed Add fallback channel and a delivery-failure queue [B:§5]
Verified lookup misses Silent manual form dob_lookup_failed, cookies cleared No explanation to the patient Explain the fallback and why it happened [B:§5] [LIVE-SRC useVerifyIdentitySignupFlow.ts:151-174]
Under 18 Blocked Client-side message Correct behavior Keep [B:§5]
Territory address Cannot complete about-you State list is 50 plus DC only No territory options Add territories or state the service area [B:§5]
Insurance not found Self-pay at $100 Try another or continue without insurance No benefits escalation queue recovered Add a benefits specialist queue [B:§5] [C:C4]
Eligibility timeout Uncertain price Copy allows up to 60 seconds No client timeout branch recovered Add timeout, retry, and save-and-resume [B:§5] [C:C4]
HIE returns nothing Manual history entry Four-step wizard No records coordinator observed Add a records chase queue with a 1 business day target [B:§5]
Questionnaire red flag Off-ramp Care team text, different SKU, unavailable screen No queue or SLA recovered Clinical triage queue with severity routing [B:§5]
No clinician licensed in state No slots booking_no_availability event No waitlist observed Waitlist and state expansion signal [B:§5] [C:C5]
No-show or late cancel Fee charged Card on file; Medicaid exempt; reschedule free Fee amount unpublished Publish the fee and show it at booking [C:C4.4]
Payment fails Cannot book Toast, stay on form No retry automation observed Dunning and save-and-resume [B:§5]
PA required Wait of several days RTPB flag, manual follow-up No dedicated PA case or submission contract recovered; staff may work in payer portals or other tools PA case object with status, owner, and deadline [D:D5.2]
PA denied Cash, switch, or abandon Manual, marketing claims follow-through No appeal workflow recovered Denial and appeal queue with reason codes [D:D5.2]
eRx never reaches pharmacy No drug, patient calls No ack or dispense state recovered; cancel and reroute Patient may be the error detector; production may have a feed Dispense and rejection feed, exception queue [E:E16] [E:E1.3]
Out of stock Delay Compare drawer and switch flags No inventory signal in inspected feed Stock check and automatic reroute [D:D5.3]
Claim rejected at counter Patient pays cash or waits No claim state recovered in the inspected GM interfaces; production state unknown No rejection feed recovered; production integration unknown Claim status integration [D:D5.3]
Mail-order checkout link missed No drug Pharmacy follow-up described; GM action unverified No GM visibility observed Status feed and outreach task [D:D5.3] [D:D16]
Cold-chain excursion Product compromised Pharmacy replacement No GM tracking or temperature telemetry recovered; production handling unknown Patient report flow and replacement case [D:D5.3]
Dose escalation needs a new PA Delay past T+28 None observed No new-strength pre-check recovered; configured workflow unknown Check PA scope before the week-4 decision [E:E5] [E:E8]
45-day offer lapse, 7.5 to 15 mg only Price may rise from the offer price No price-window reminder in inspected client Condition runs from delivery or receipt of the previous fill, not purchase date Remind from the recorded receipt date; do not apply to 2.5 or 5 mg [PUBLIC https://zepbound.lilly.com/savings/terms-and-conditions]
Check-in not completed Renewal may be affected criteria_deadline and card The GLP-1 blocking rule and exception owner are unverified; same-strength refills depend on prescription, pharmacy and payer Verify the configured pathway rule before displaying a hard block [E:E5] [E:E6]
Severe side effect after hours No GM clinical response path recovered; production handling unknown 911 instruction observed; GM after-hours clinical route not recovered No nurse line or on-call clinician observed After-hours triage line and escalation playbook [E:E16]
Patient stops treatment No record, no transition in inspected client No complete stop workflow recovered; production handling unknown No distinct stop state recovered Stop and transition flow with records and billing [E:E11]
Replay or analytics leak Privacy exposure risk No consent gate observed; replay default allow Specific GLP-1 capture, runtime masking, retention and destination access unverified Consent management, masking, and vendor BAA review [A:A3.4]
Billing literals differ from the reconstructed spec Wrong charge or no charge risk Client checks gm_card and pharmacy_delegated; reconstructed spec uses cash and pharmacy_delegation Authoritative server BillingType unverified One schema, contract tests, and reconciliation [D:D5.4]
State-to-entity mapping unverified Wrong entity or consent risk Server-side practiceId filter Legal addresses and NPPES jurisdictions differ; not proof of a defect Publish and test a state-to-entity matrix [D:D5.4]
Metabase login shell is publicly reachable Network exposure risk Sign-in page observed; data access not established SSO configuration and permissions require review SSO, network restriction, and audit [F:F4.1]
No good-faith estimate for self-pay Patient cannot see an itemized expected cost Per-SKU prices and checkout totals in inspected surfaces; no estimate artifact recovered No GFE artifact or delivery flow recovered Add a GFE queue: 1 business day for 3 to 9 business days ahead, 3 business days for 10 or more ahead or a pre-scheduling request [PUBLIC https://www.cms.gov/initiatives/your-patient-rights/medical-bill-rights/get-help/guides-resources/what-good-faith-estimate]
No accessibility or interpreter path Patient cannot complete intake or the visit None observed No accommodation queue, captions or interpreter workflow observed Add an access-needs field and a staffed accommodation queue [INFERENCE: common practice]
Pen needles not observed in the catalog Patient may not be able to inject a KwikPen Label and pharmacy counseling; pharmacy may supply or co-dispense No needle or sharps SKU observed, no supply check Add a supply bundle or a required counseling step at first fill [E:E2] [E:§6 q14]
Carrier scan treated as possession Wrong address, damage, or temperature excursion goes unnoticed Pharmacy-side tracking described; GM visibility unverified No patient possession confirmation observed Ask for possession confirmation and route exceptions to the pharmacist [INFERENCE: common practice] [D:D17]
No contraception counseling field Label counseling requirement can be missed at start and at escalation Clinician judgment; care may occur without a structured field No structured field or reminder observed Add counseling and a 4-week backup-method reminder to the visit and week-4 criteria [PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §8.1] [D:D6]
No T0 administration record Refill clock may be anchored to payment or shipping No administration endpoint observed Possession, administration, delayed start and decline are not distinguished Ask for patient-reported T0 or retain start unknown; never infer from claim or delivery [INFERENCE: proposed control]
PA approval not linked to claim Approval may not produce a paid or dispensed fill No re-adjudication object observed Approval scope, expiry and claim result are not carried together Record approval scope and require pharmacy re-adjudication before promising a fill [D:D5.3] [INFERENCE: common practice]
Product-specific safety review not evidenced Contraindication and warning handling may be inconsistent Clinician judgment; no structured field observed Source version, finding, decision and advice are not captured together Add a structured safety review and escalation owner [PUBLIC Zepbound PI §§4-5, 7-8]

10. Technology plan inputs

10.1 Systems and integrations

Capability Current state observed Build, buy, or partner Data contract needed Gap to avoid or fix Evidence
Patient identity and session Cognito with phone OTP through Twilio; Google SSO in code but not live Buy Phone, OTP challenge, session, isExistingUser, tenant Add email or voice fallback; define duplicate-account and phone-reuse rules [B:H2] [B:H3]
Identity autofill Verified 1-Click Signup after phone and DOB Buy Request: phone and DOB; response: name, sex, email, addresses, confidence No error surfaced on miss; log and explain the fallback [B:H4]
Identity proofing Persona wired for in-person and a generic pre-visit requirement; GLP-1 trigger unknown Buy Inquiry id, document type, liveness result, manual attestation Define which GLP-1 cases require KYC and who can attest [B:H22]
Insurance discovery Verified candidate plus payer directory and card OCR Buy or partner Payer, member id, group, plan, network, copay, deductible One source of truth; timeout and retry semantics [B:H5] [B:H8] [B:H11]
Eligibility and claims Waystar inferred from hosts; no payload observed Buy X12 270 and 271, error codes, payer ids, service types Add idempotency, audit trail, and a benefits exception queue [B:H8] [C:H11]
HIE Metriport primary, Particle secondary Buy FHIR Condition, MedicationStatement, AllergyIntolerance, Procedure; consent; source tag Provenance and freshness required; no silent empty chart. Privacy and compliance must verify notice version, applicable disclosure or authorization basis and opt-out status on both Verified and manual signup branches before HIE retrieval. Carry source, timestamp and effective opt-out status into chart and AI prewarm; honor the published opt-out. Missing or conflicting evidence routes to privacy review and manual history, not presumed permission. Production enforcement unverified [B:H13] [B:H14] [PUBLIC https://generalmedicine.co/hipaa-privacy-practices]
Scheduling and visits Nile-Core plus Visitron; 20-minute slots, 9 per 4-hour block Build Visit id, SKU, modality, state, clinician, location state, price Add a claim or assignee primitive to review queues [F:F3.2] [DATA internal_portals_recon.json → visitron.rtk_endpoints]
Video Zoom link by SMS and email Buy Meeting URL, id, passcode, join status No attendance or connection-failure event observed [E:H12] [C:C8]
eRx DoseSpot SSO and NCPDP SCRIPT to NCPDP id Buy Rx payload, NCPDP id, refills, SIG, days supply, cancel and replace Single point of failure; needs outage playbook and fallback [D:H5] [F:F3.1]
Benefit check Arrive Health RTPB plus DoseSpot RTPB Buy Patient, drug, NDC, pharmacy, copay, formulary, PA flag, inquiry id No PA submission or appeal object recovered; production workflow unknown [D:H7]
EHR of record Athenahealth sync and resync Buy Encounter, diagnoses, orders, care plan, athena_id Resync failures need a queue and reconciliation [D:H4]
Ambient scribe Nabla status and note draft Buy Audio, transcript, note draft, status Define retention and consent for audio [D:H6]
Care plan and next steps Care::Plan plus AI draft and clinician sign-off Build proposed_json, final_json, rationale, state, next-step cards Prompt version and model must be recorded per output [E:E1] [F:F3.3]
Patient copilot /ai with Metriport prewarm and Braintrust feedback Build plus partner Consent, context, messages, feedback, model version Clinical guardrails, escalation, and PHI handling unproven [E:E13] [F:F3.3]
Pharmacy directory Live REST feed with NCPDP ids, prices, distance, fulfillment_owner Build aggregator plus partner feeds NCPDP id, chain, price, distance, fulfillment owner No in_stock, hours, city, state, or tracking [D:D12] [A:H15]
Pharmacy order Four-state chain is a dossier hypothesis; client exposes a state string plus flags Build Order id, NCPDP id, billing type, price, state, flags No dispense, ack, reject or tracking field recovered; production feed unknown [D:D11-D15] [E:E1.3]
Mail-order handoff eRx to LillyDirect, Amazon, NovoCare; patient pays the pharmacy Partner Rx, patient, NCPDP id, checkout status, ship status No return-status contract recovered; verify existing pharmacy feeds and staff workflows before building another integration [D:H10] [D:H11]
Retail handoff eRx plus NCPDP claim; prepaid card or GM card Partner Rx, claim, copay, rejection, dispense No claim-rejection or dispense state recovered; production integration unknown [D:H13]
Inventory and substitution No inventory signal in the inspected comparison feed; production stock feeds unknown Buy or partner NDC, strength, quantity on hand, backorder, ETA Add stock check before promising a fill date [D:D5.3]
Payments Stripe SetupIntent, payment method, charge, 3DS Buy Payment method id, amount, status, refund, idempotency key Visit charge capture timing inferred, not observed [C:H1]
GM card and discount switch BIN, PCN, group, member id Partner, sponsor unknown Card identity, eligibility, claim routing, remittance Two instruments share one name; model separately [D:D4.3] [C:H14]
Good-faith estimate No compliant estimate artifact recovered; per-SKU prices only Build Trigger, self-pay status, issuing entity, dated itemization, delivery evidence, dispute reference Deliver within 1 business day for 3 to 9 business days ahead, within 3 business days for 10 or more ahead or a pre-scheduling request [PUBLIC https://www.cms.gov/initiatives/your-patient-rights/medical-bill-rights/get-help/guides-resources/what-good-faith-estimate]
Identity assurance policy OTP plus Verified autofill or manual fallback; Persona trigger unknown Build plus partner Accepted evidence, risk trigger, verification method, verifier, time, duplicate-chart resolution Define before prescribing; do not equate autofill with proofing [B:H4] [B:H22]
Manufacturer savings and COB No field or workflow recovered Build or partner Program and version, approved use, government exclusion, primary claim, secondary claim, caps, expiry, accepted price Eligibility and redemption unverified; model separately from GM card [D:D4.4] [PUBLIC https://zepbound.lilly.com/savings/terms-and-conditions]
Labs Junction and Vital; Quest, Labcorp, BioReference Buy Order, requisition, accession, result, critical flag, PDF Fee components outside total; delegated-flow mode unknown [C:H5] [C:H6]
Lab results Dashboard, Updates, PDF, abnormal_results_count Build plus partner Result status, reference range, interpretation, critical call No patient-facing critical-result SLA [C:C21]
Messaging Twilio Conversations and SMS 98528; Message Center behind a flag Buy Conversation id, subject, response_expectation, attachments Support and clinical messaging overlap; one owner needed [E:H11] [F:F3.2]
Email Unidentified vendor Buy Template, event, delivery status Vendor and BAA unknown [E:H15]
Product analytics Segment through a first-party proxy Buy Event schema, identity resolution, consent, destination list No complete analytics schema or consent-enforcement mechanism recovered; email and phone appear in guarded client calls. Backend governance and runtime sending remain unverified [A:H7]
Replay and monitoring Datadog RUM and Logs at 100 percent Buy Session, user id, redaction rules Explicit phone masking marker found; other component masking and runtime behavior unverified [A:H8]
Feature flags LaunchDarkly with reporting Buy Context key, flag version, evaluation Flag state mirrored to Datadog, useful for audit [A:H9]
Warehouse and BI Databricks plus Metabase 1.63.10; the login shell is public and requires sign-in Build and operate Table contracts, lineage, access policy Network exposure requires review; unauthenticated data access not established [F:F4.1]
Prior authorization No dedicated PA case, submission or appeal contract recovered in the inspected client or portal inventories; staff may use payer portals or other tools Build or partner Case id, payer, drug, NDC, criteria, evidence, status, deadline, appeal Highest operating gap on the insured path [D:D5.2]
Dose and adherence No dose-administration event recovered in the inspected client surfaces; production may record this elsewhere Build Dose event, device, site, timestamp, missed-dose reason Cannot distinguish stable from stopped from the inspected data [E:E4]
Weight and vitals Only typed into questionnaires or recorded at visits in the inspected surfaces; production device sync unknown Build or partner Measurement, date, source, unit No device integration observed [E:E12]
Catalog and pathways Catalog with 106 operations, one cache tag Build SKU, option, phase, criteria, questionnaire, codes, lab panel Add approval workflow beyond questionnaires and pathways [F:F0.1]
Refunds No refund endpoint in the inspected public or internal API inventories; execution may use Stripe or back-office tools Build or partner Order id, payment id, reason, amount, status Refund execution system unverified [C:C3]

10.2 Data contracts and identifiers

The journey needs a crosswalk, not one global identifier. Each boundary must carry enough to reconcile:

Boundary Identifier Required fields Failure semantics Status Evidence
Patient record patient_id, signup_id Phone, DOB, name, address, consents, tenant Duplicate match, phone reuse, partial record Observed [B:B7]
Visit visit_id SKU, modality, clinician, state, price, billing type Hold expiry, no-show, reschedule Mixed; enum unverified [F:F3.2]
Questionnaire questionnaire_id, response_id Version, question id, answer, submitted at Partial submission, edited version Observed fields; content unrecovered [B:B11]
Prescription prescription_id, care_action_prescription_id Drug, NDC, strength, form, quantity, days supply, refills, NCPDP id Finalize failure, cancel, replace Observed [D:D8]
Pharmacy order pharmacy_order_id NCPDP id, billing type, price, state, payment id Ack timeout, reject, dispense, cancel Mixed; state model proposed [D:D11-D15]
Lab order lab_order_id, accession_number Panel, network, fee, collection status, result No-show, redraw, critical value Mixed; enum unverified [C:C19-C21]
Payment payment_method_id, payment_intent_id Amount, currency, status, refund, idempotency key 3DS required, declined, duplicate charge Observed [C:C7]
PA case pa_case_id, payer case number Drug, NDC, criteria, evidence, status, deadline Missing information, denial, appeal Proposed [D:D5.2]
Conversation conversation_id Subject, participant, response_expectation, attachments Delivery failure, after-hours Observed [E:E3]
Shipment Carrier tracking id Order id, address, ship date, exception Lost, delayed, temperature excursion Proposed [D:D17]
Dose event dose_event_id Prescription and fill id, status, scheduled and administered time, source, reason Never started, missed, delayed, declined, unknown Proposed [INFERENCE: common practice]

No recovered contract covers a pharmacy acknowledgment and dispense event, a PA case, or a dose-administration event. The shapes below are proposed, not implemented. Each needs a version, timestamp semantics, idempotency key, source of truth, reconciliation owner, and a verified producer-consumer pair.

type PharmacyBillingType =
  | "cash_prepaid_retail"
  | "gm_discount_card_retail"
  | "direct_mail_cash"
  | "commercial_insurance"
  | "government_insurance";

interface PharmacyOrderContract {
  pharmacy_order_id: string;
  prescription_id: string;
  patient_id: string;
  medication_option_sku_id: string;
  ndc11: string;
  presentation: "kwikpen_multidose" | "autoinjector_singledose" | "vial_singledose" | "vial_multidose";
  strength_mg: 2.5 | 5 | 7.5 | 10 | 12.5 | 15;
  package_count: number;
  doses_per_package: number;
  dose_volume_ml: number;
  concentration_mg_ml: number;
  total_volume_ml: number;
  days_supply: 28;
  companion_supplies: { pen_needles: boolean; syringes: boolean; sharps_container: boolean };
  ncpdp_provider_id: string;
  billing_type: PharmacyBillingType;
  transmission_state: "created" | "pharmacy_selected" | "erx_transmitted" | "erx_acknowledged" | "erx_error_or_clarification";
  claim_state: "not_submitted" | "adjudicating" | "rejected_pa_required" | "rejected_other" | "paid" | "reversed";
  dispense_state: "not_dispensed" | "ready" | "dispensed" | "partially_dispensed" | "canceled";
  shipment_state?: "not_shipped" | "shipped_cold_chain" | "carrier_delivered";
  possession_state: "unknown" | "confirmed" | "not_received" | "wrong_item" | "damaged";
  exception_state?: "none" | "temperature_reported" | "product_complaint" | "open";
  dispensed_at?: string;
  carrier_delivered_at?: string;
  possession_confirmed_at?: string;
  idempotency_key: string;
  updated_at: string;
}

interface PriorAuthCaseContract {
  pa_case_id: string;
  patient_id: string;
  prescription_id: string;
  pharmacy_order_id?: string;
  payer_id: string;
  raw_reject_code?: string;
  reject_code_set_id?: string;
  reject_code_set_version?: string;
  classification_version?: string;
  classified_reject_reason?: "pa_required" | "plan_exclusion" | "plan_limitation" | "dur" | "other";
  submission_channel: "epa" | "payer_portal" | "fax" | "unknown";
  external_case_number?: string;
  submission_receipt?: string;
  submitted_evidence_versions?: string[];
  payer_message?: string;
  indication: "obesity_bmi_30" | "overweight_bmi_27_comorbidity" | "osa_obesity" | "t2d";
  baseline_bmi?: { value: number; measured_at: string; source: "intake" | "hie" | "visit" };
  status: "open" | "submitted" | "rfi_pending" | "approved" | "denied" | "appeal_submitted" | "appeal_decided" | "cash_fallback" | "closed_abandoned";
  submitted_at?: string;
  rfi_due_at?: string;
  rfi_history?: Array<{
    request: string;
    received_at: string;
    due_at: string;
    owner: string;
    response_evidence_versions: string[];
    response_sent_at?: string;
    response_receipt?: string;
  }>;
  approved_scope?: {
    auth_number: string;
    product_ndc: string;
    presentation: string;
    strengths: string[];
    quantity: number;
    days_supply: number;
    effective_from: string;
    expires_at: string;
  };
  denial_reason?: string;
  appeal_deadline?: string;
  appeal_decision?: string;
  claim_result?: "paid" | "rejected" | "reversed" | "not_reprocessed";
  final_claim_ref?: string;
  abandonment_evidence_ref?: string;
  pharmacy_reprocessed_at?: string;
  linked_dispense_or_reversal?: string;
  closure_reason?: string;
  sla_due_at: string;
}

type DoseEventStatus = "planned" | "administered" | "missed" | "delayed" | "declined" | "unknown";

interface DoseEventBase {
  dose_event_id: string;
  patient_id: string;
  prescription_id: string;
  fill_id: string;
  reported_at: string;
  source: "patient_reported" | "clinician_recorded" | "device";
  reason?: string;
  injection_site?: "abdomen" | "thigh" | "upper_arm_caregiver";
  contraception_backup_counseled: boolean;
}

type DoseEventContract = DoseEventBase & (
  | { status: "administered"; administered_at: string; scheduled_at?: string }
  | { status: "planned" | "missed" | "delayed" | "declined" | "unknown"; administered_at?: never; scheduled_at?: string }
);

Invariant: for administered status, administered_at is required; scheduled_at is optional. For planned, missed, delayed, declined or unknown status, administered_at is absent and scheduled_at is optional when the schedule is unknown. Derive T0 only from an accepted administered event with a timestamp and source, never from scheduled_at, possession or shipment. Validate at ingestion.

PA invariant: do not mark an RFI satisfied or a case successfully closed without its receiving and closure evidence. Preserve the payer message, reject_code_set_id and reject_code_set_version separately from classification_version. A PA approval covers only the product, NDC, presentation, quantity and days supply recorded in approved_scope; do not assume it covers another presentation because a strength matches. Close a case only with final_claim_ref or abandonment_evidence_ref plus closure_reason.

10.3 Implementation gaps a builder should avoid

  1. Do not default a drug family to its most expensive presentation. Make price part of the default selection logic.
  2. Do not put indexable pages outside the sitemap and noindex pages inside it.
  3. Do not send email, phone, and condition context to a product analytics tool without a BAA and a consent basis.
  4. Do not initialize 100 percent session replay with defaultPrivacyLevel: allow on routes that may render clinical intake or PHI. Enforce mask-user-input, gate replay on consent, and verify the actual clinical surfaces before launch. [A:A3.4]
  5. Do not name two different payment instruments "card". A prepaid payment card and a discount BIN are separate objects.
  6. Do not let client and server enums drift. Generate both from one schema.
  7. Do not model a pharmacy order without an acknowledgment, rejection, and dispense state.
  8. Do not render a claim of "we handle prior authorization" without a PA object, owner, and SLA behind it.
  9. Do not calculate prescription quantity from a field whose unit is ambiguous.
  10. Do not expose a BI tool without authentication, even on a staging host.
  11. Do not launch a state without a signed state-to-professional-entity matrix.
  12. Do not treat a session cookie with a 30-minute life as durable SKU attribution for a high-consideration purchase.

11. Operating plan inputs

11.1 Queues to stand up

Queue Trigger Owner Proposed target, design not observed Volume driver Evidence
Identity exception OTP failure, Verified miss, under-18, territory address Support 1 business day Signup attempts [B:§5]
Benefits and eligibility Not found, timeout, multiple plans, out of network Care coordinator or benefits specialist 1 business day Insured bookings [B:§5] [C:C4]
Clinical intake red flag Questionnaire off-ramp: emergency, urgent, high_risk, requires_triage, unable_to_treat, different_sku Licensed clinician Emergency immediate; urgent prompt triage; high risk or requires triage before booking; unable to treat with alternate disposition; different SKU by clinical approval Screening completions [B:B11] [CODE lib/analytics/questionnaireInterstitialAnalytics.ts:3-9]
No availability No licensed clinician in state Operations Same day response with waitlist State supply [B:§5] [C:C5]
No-show and late cancel Visit state transition Care coordinator 1 business day outreach Booked visits [C:C4.4]
PA new request RTPB flag or pharmacy rejection PA specialist plus prescriber 1 business day to open, daily follow-up Insured fills [D:D5.2]
PA denial and appeal Payer denial RCM plus prescriber Notify patient 1 business day, appeal within plan deadline Insured fills [D:D5.2]
Pharmacy transmission failure No acknowledgment within 1 business day Pharmacy liaison Same day resend or reroute All fills [E:E16]
Out of stock and reroute Pharmacy reports stockout Pharmacy liaison Same day alternative All fills [D:D5.3]
Lab collection overdue Order not collected in 5 days Lab navigator 1 to 2 business days outreach Lab orders [C:C20]
Lab abnormal or critical Result flag or critical webhook Clinician Critical immediate, routine 1 business day Lab orders [C:C21]
Week-4 check-in incomplete Criteria deadline near Care coordinator 3 business days before deadline Active patients [E:E6]
After-hours symptom Message or call outside shift Clinical triage Immediate emergency direction. Suspected pancreatitis: stop tirzepatide and arrange immediate clinician contact or urgent assessment, not a next-shift reply Active patients [PUBLIC Zepbound PI §5.5] [E:E16]
Refund and billing Request or policy eligibility Support and RCM 1 business day acknowledgment All payments [C:C4.4]
Records request Patient request or transfer Privacy officer Statutory deadline, commonly 30 days All patients [PUBLIC https://www.law.cornell.edu/cfr/text/45/164.524]
Good-faith estimate request Self-pay or uninsured patient requests or schedules applicable care Billing and compliance 3 to 9 business days ahead: within 1 business day. 10 or more business days ahead, or requested before scheduling: within 3 business days Self-pay bookings [PUBLIC https://www.cms.gov/initiatives/your-patient-rights/medical-bill-rights/get-help/guides-resources/what-good-faith-estimate]
Adverse event and product complaint Reported side effect, product defect, damage or temperature issue Licensed clinician plus Medical Director Urgent care first; separate reporting review and product-complaint follow-up Active patients and fills [PUBLIC Zepbound PI §17]
Possession, training or start delay Possession or training unresolved at the agreed follow-up time, or no reported actual start three calendar days after the patient-reported planned start date. If the planned start is unknown, open a coordination task on confirmed possession; never compute an overdue threshold from an absent T0 Care coordinator and pharmacist 1 business day outreach after the defined trigger Every fill [INFERENCE: proposed queue]
Dose continuity risk Pen supply ends before next fill is in hand Care coordinator and PA lead Same day escalation and reroute Active patients [E:E5] [INFERENCE: proposed queue]
Identity, credential or authority exception Duplicate chart, manual-entry mismatch, expired license, travel, no eligible clinician, pharmacy refusal Compliance and clinical operations Hold unsupported care; same-day routing to licensed reviewer Signup and booking [PUBLIC https://www.mbc.ca.gov/Resources/Medical-Resources/telehealth.aspx]

Proposed queue contract: record the workflow, patient and trigger-event case key, system of record, intake time, accepting role, acceptance time, next-update due time, escalation and evidence-backed closure. Routine targets use staffed business hours, explicitly scheduled in America/New_York; urgent clinical intake and safety cases require a staffed 24/7 accepting clinical service and backup. If that service is not provisioned, do not promise an immediate GM response: provide the approved external urgent or emergency route. Close only with documented receiving acknowledgment and disposition, not message delivery. Operations must populate hours, backup and workflow-specific closure evidence for every row and obtain clinical and compliance approval before publishing a service target. "Immediate," "same day" and "one business day" are design targets, not observed GM service contracts.

Off-ramp value Proposed action Owner
emergency Immediate emergency-services direction and urgent handoff Licensed clinician
urgent Prompt licensed triage before any booking or prescribing Licensed clinician
high_risk or requires_triage Clinician review before checkout or prescribing proceeds Licensed clinician
unable_to_treat Explicit explanation and alternate-care or referral disposition Clinician and care coordinator
different_sku Clinician-approved alternate pathway preserving relevant answers and provenance Clinician and catalog

11.2 Staffing drivers

  • Video capacity: 20 minutes per visit, 9 per 4-hour block, 36 clinical hours per week for a full-time physician. That is 81 visits per week at full density or 3,888 per year across 48 working weeks. This is a capacity ceiling, not staffed capacity. [F:F3.4]
  • Chat capacity: a 3-hour response window, with chat shifts extended when the queue is long. [F:F3.2]
  • Care coordination: one coordinator per unknown number of active patients. The only observed cost is $22 per hour. [F:F3.4]
  • PA and pharmacy liaison: no such role or queue appears in the 16 open requisitions or inspected portal inventories; production staffing unknown. Staff this from measured arrivals and handling time, not from the org chart.
  • Clinical review at week 4: one review per active patient per month while titrating, then roughly every three months. [LIVE GLP-1 guide]
  • Lab follow-up: one result review per order, with outreach only on abnormal results. [C:C21]
Illustrative workload per 1,000 new starts and 1,000 month-2 renewals Assumption Hours per month FTE at 144 productive hours Basis
Video visits 70 percent of 1,000 initial encounters are video; independently assume 35 percent of 1,000 renewal reviews need video: 700 initial plus 350 renewal at 26.7 minutes 467.3 3.2 [F:F3.4] [INFERENCE: planning assumption]
Chat and async reviews 300 initial chats plus 650 check-in reviews plus 250 lab or side-effect reviews at about 10 minutes 200 1.4 [F:F3.4] [E:E7]
PA and pharmacy liaison 500 initial PA checks plus 250 step-up checks at 25 minutes, plus 300 follow-ups at 10 minutes 362.5 2.5 [F:F3.4] [D:D5.2-D5.3]
Support and lab navigation 400 support contacts at 10 minutes plus 600 lab follow-ups at 5 minutes 116.7 0.8 [F:F3.4] [C:C3]
Total before coverage Sum of the rows 1,146.4 8.0 [INFERENCE: arithmetic]

These are illustrative planning assumptions, not observed volumes, arrival rates, handling times or productivity. The 144 productive hours per FTE, 26.7-minute video assumption and 10/25-minute handling times are model inputs. Add coverage, leave, shrinkage and arrival variability before deciding headcount.

11.3 Scripts and playbooks

Situation Playbook content
Price explanation Separate visit fee, lab fee and drug price. The public catalog does not quote this patient's insured drug cost; after prescribing, RTPB may produce an estimate, and the pharmacy's adjudicated claim sets the payable amount.
Wrong default form Explain KwikPen versus auto-injector versus vial, with the $299 versus $1,074.09 difference. The 45-day condition applies only to the 7.5 to 15 mg KwikPen purchase offer and runs from delivery or receipt. Re-quote the 5 mg SKU.
Insurance not found Offer another plan, card photo, or self-pay at $100. Do not imply coverage.
PA required Explain who submits, the expected several business days, the patient's financial responsibility, and the cash alternative. Track submission receipt and approval scope.
PA denied Explain the denial reason, appeal rights and deadline, cash price, and alternative drug. Do not promise a reversal.
Pharmacy has no Rx Confirm the NCPDP id, resend, or reroute. Give the patient a case owner and a next update time.
Out of stock Offer a switched pharmacy or mail order, state the new price, and cancel the old order to avoid a duplicate fill.
Side effects Triage severity. Emergency symptoms receive immediate emergency-services direction. Suspected pancreatitis requires stopping tirzepatide and immediate clinician contact or urgent assessment, not a paid visit or next-shift wait. Persistent vomiting, diarrhea, dehydration, severe abdominal pain or gallbladder symptoms need same-day clinical assessment and renal-function review. Do not let a $30 to $100 visit fee delay urgent triage.
Hypoglycemia and diabetes drugs For insulin or a secretagogue, document whether dose reduction is indicated, the glucose-monitoring plan, hypoglycemia signs and the escalation route. Do not adjust another prescriber's insulin without coordination.
Cold chain and storage Refrigerate at 2 to 8 C, never freeze; room temperature means no more than 30 C. Total room-temperature exposure is cumulative. Never use a previously frozen product. Single-dose pen or vial: up to 21 total days at 30 C or below, then discard. Unopened multi-dose vial or KwikPen at room temperature: discard after 30 days. Opened: discard after 30 days at room temperature, 30 days after first use, or after 4 weekly doses, whichever comes first. Assess any damaged or warm product with the pharmacist; do not tell the patient to re-chill and inject.
Savings and coordination of benefits Verify the current program, product and presentation, approved-use eligibility, government-program exclusion, pharmacy, quantity and days supply, caps and expiration. Record the primary claim outcome, any permitted secondary claim, approval or rejection, remaining cap and the patient's accepted price. Explain a denied savings claim before accepting a replacement cash price.
Missed dose Take within 96 hours, otherwise skip and resume the regular day. The weekly day may change if at least 72 hours separate doses. Prolonged interruption needs clinician review before restart. Do not double dose.
Contraception Tirzepatide delays gastric emptying and can reduce oral contraceptive exposure. Counsel on a non-oral method or backup for 4 weeks after initiation and after each escalation; repeat at week 4. Record the advice.
Supplies Confirm the device, needle type, sharps disposal, and whether the box includes what the patient needs. No needle SKU was observed in the catalog; the pharmacy may supply or co-dispense.
Refund Visit fee if canceled at least 24 hours ahead. A lab refund may be requested within 6 months of purchase if the sample has not been collected; eligible refunds have no fee deduction. No refund for service provided.
Records Verify identity, log the request, route to the custodian for the relevant entity, and track the applicable deadline. Account closure is not medical-record deletion.
Stop or transfer Stop the prescription, cancel future orders, explain billing, and provide records.
Privacy request Verify identity, log the request, and route to the privacy officer.

11.4 Compliance artifacts

Artifact Status Evidence
LegitScript certification Badge and outbound link in the footer [F:F8]
HIPAA Notice of Privacy Practices Live, last updated 2025-11-03, issued by the PCs [F:F8]
Privacy notice Live, last updated 2026-09-02, Path Healthcare Systems Corp. [F:F8]
Telehealth consent Emerald consent plus a separate Vital consent naming delegated entities [F:F8]
Vendor BAAs Not observed; no subprocessor list [F:F8]
Pharmacy licensure No verification UI or field recovered [F:F8]
NP collaborative practice agreements Managed by a dedicated licensure manager [F:F8]
Prescriber licensure State per booking, 50 states plus DC claimed, server-side filter; enforcement unverified and invalid state XX was accepted at availability [F:F8] [B:§5]
CPOM and Friendly PC Five PCs by state; NPPES addresses and jurisdictions differ; state-of-care to entity to clinician mapping unverified, not proof of a defect [F:F8] [D:D0.3]
PCI Stripe and Trust Commerce [F:F8]
Identity Persona wired for some flows; GLP-1 trigger unknown; manual attestation fallback [F:F8] [B:H22]
Good-faith estimate No compliant estimate artifact recovered; per-SKU prices only. Required timing: 1 business day for 3 to 9 business days ahead, 3 business days for 10 or more ahead or a pre-scheduling request [PUBLIC https://www.cms.gov/initiatives/your-patient-rights/medical-bill-rights/get-help/guides-resources/what-good-faith-estimate]
Records custody and retention No complete schedule, export endpoint or audio-retention policy recovered. HIPAA documentation floor is 6 years; state chart retention varies; define S3 lifecycle for cards and lab PDFs and a post-sign-off audio policy [PUBLIC https://www.law.cornell.edu/cfr/text/45/164.530] [PUBLIC https://www.law.cornell.edu/cfr/text/45/164.524]

11.5 KPIs per stage

Stage KPI Definition Current value Evidence
A Organic landing conversion Sessions that start signup Not observable [A:A2]
A Wrong-price exposure Sessions that view the $1,074.09 default Not observable [A:A5.1]
B Signup completion OTP verified to patient record Not observable [B:B7]
B Verified match rate Autofill success over attempts Not observable [B:§5]
B Insurance success rate Eligibility confirmed over attempts Not observable [B:B9]
B Questionnaire completion Submitted over started Not observable [B:B11]
B Off-ramp rate Off-ramps over completions, by type Event exists, value not observable [B:B11]
C Booking conversion Paid bookings over completed screens Not observable [C:C7]
C No-show and cancellation No-show events over booked eligible encounters, independent of fee assessment Not observable [C:C9] [CODE utils/cancellationFeeUtils.ts:43-53]
C Lab attach rate Lab orders over visits Not observable [C:C15]
C Lab collection rate Collected over ordered Not observable [C:C20]
D Visit completion Completed over booked Not observable [F:F3.2]
D Prescription rate Rx finalized over completed visits Not observable [D:D8]
D Time to prescription Visit start to Rx finalized Not observable [D:D8]
E Time to fill Two measures: Rx finalized to dispense, and checkout to dispense. Include PA delay and abandoned orders Not observable [D:D11-D17]
E Direct-pay share LillyDirect or Amazon over all fills Not observable [D:D12]
E Dispense confirmation Confirmed dispense over transmitted Rx No dispense event recovered [E:E1.3]
E Possession confirmation Patient-confirmed possession over dispensed No possession event recovered [INFERENCE: common practice]
E PA submission to decision Business days from submission to payer decision; approval is not a paid claim No PA case event recovered [D:D5.2] [INFERENCE: common practice]
F T0 completeness Patients with a recorded or patient-reported first dose over patients with a dispense No T0 event recovered [INFERENCE: common practice]
F Check-in completion Check-ins completed by T+20 over patients due Not observable [E:E6]
F On-time transition Second fill in hand by T+28 over patients with a recorded T0 Not observable [E:E5]
F Escalation rate Side-effect or adjustment visits over active patients Not observable [E:E16]
F Second-fill persistence Patients with a second fill over patients with a first fill; a dispensing measure, not adherence Not observable [E:E8]
F Clinically approved continuation Patients continued by a clinician over eligible patients Not observable [E:E7]
F Intentional stop with transition Documented stops with a transition plan over documented stops Not observable [E:E11]
F Support contacts per patient Conversations or SMS over active patients Not observable [E:E3]

Proposed target bands, for design discussion only and not observed GM service levels: OTP verification above 90 percent; eRx acknowledgment within 15 minutes for at least 98 percent; PA submission within 1 business day; check-in started by T+18 for at least 85 percent; second box in hand by T+27 for at least 90 percent; critical lab call immediate. [INFERENCE: proposed targets]


12. Discrepancies and open questions

12.1 Conflicts between sources, resolved or open

# Conflict Stronger evidence Resolution Status Evidence
1 Zepbound "from $299" versus a default SKU at $1,074.09 Live cash price per SKU Two SKUs: 710641 KwikPen $299, 710642 auto-injector $1,074.09; the family default is the expensive one Resolved, product defect remains [A:A5.1] [LIVE /api/external/medication_option_skus/710642/cash_price]
2 Lab components sum to $141.58 but total is $86.58 Live lab_skus plus component code total_cash_price is test price plus $15 clinical fee; platform, order and collection fees are outside the total. Panel 503263 returns $40 platform, $6 order, $9 Quest collection Resolved [C:C4.3] [F:F5.2] [LIVE /api/external/lab_skus/503263]
3 Clinical fee $15 versus $30 Live data on 10 SKUs $15.00 is live; $30 is only the client fallback when the field is missing Resolved [C:C4.3] [CODE types/enums/lab-pricing-constants.ts:8]
4 Chat price $30 versus $35 Live sku_options $30 live; $35 is a code fallback Resolved [D:D5.4] [LIVE /api/external/sku_options/300543]
5 Cancellation fee amount Policy page plus client fallback Policy does not publish an amount; $25 is the client fallback; video only; Medicaid exempt Open [C:C4.4] [CODE utils/cancellationFeeUtils.ts:24-26]
6 Number and states of Friendly PCs Legal docs, NPPES, privacy notice Names and recorded addresses differ across sources. The state-of-care to furnishing entity to clinician to billing NPI mapping is unverified; address differences alone do not establish a licensure or CPOM defect Open [LIVE /terms-of-service] [LIVE /privacy-policy] [PUBLIC NPPES] [F:F7]
7 37 versus 38 states in Care::Plan Client map The 37-state map is a shared UI grouping across care actions, not a Care::Plan enum; the 38th state and the server enum are unverified Resolved as a UI count, open as an enum [F:F7] [CODE components/CareActions/careActionSection.ts:40-92]
8 "We take care of prior authorizations" versus no PA contract Assignment of benefits plus API inventory Marketing claim; AOB places responsibility on patient or referring physician; no dedicated PA case or submission contract was recovered. Staff may work in payer portals Open, ownership unclear [D:D5.2] [LIVE /assignment-of-benefits]
9 LillyDirect is one partner or many LillyDirect FAQ plus NPPES NCPDP endpoint is LillyDirect Pharmacy LLC; dispensing is by Amazon, Fuze Health, Gifthealth, Prescryptive, or Walmart. Gifthealth publishes a different self-pay NCPDP 3692539; product-level routing is unverified Resolved as a set, open as routing [D:D0.3] [LIVE https://www.lilly.com/lillydirect/faq] [PUBLIC https://www.gifthealth.com/faq-topics/prescriptions-getting-started]
10 in_stock in the data model versus live payload Live pharmacy_comparisons No inventory field live Resolved, model is stale [D:D0.3] [LIVE pharmacy_comparisons]
11 gm_card and pharmacy_delegated versus cash and pharmacy_delegation Client helper literals plus reconstructed OpenAPI Source and specification differ. The OpenAPI is explicitly reverse-engineered, so this is not a demonstrated server enum defect; the authoritative BillingType is unverified Open, blocks reconciliation [D:D5.4] [DOC openapi.yaml:1-8,257-262,1241-1246]
12 Pharmacy order state chain versus client contract Client API plus data model Four-state sequence is a dossier hypothesis; client exposes a state string plus cancel and switch flags. No ack, dispense or tracking field recovered; server feed unknown Open [E:E7] [CODE lib/store/api/pharmacyOrderApi.ts:15-24]
13 Lilly page CTA to 201448 with allows_first_fill:false Live SKU data plus page New starts should use 300543; the CTA is a funnel mismatch Open, intent unknown [D:D0.3] [LIVE /p/lilly/weight-loss]
14 Prescription quantity units Live PDP payloads Zepbound KwikPen 2.4 "Injection pens", auto-injector 2.0, Mounjaro 1.0; units look like mL mislabeled Open, do not generate quantity from it [D:D0.3] [LIVE product_detail_pages]
15 ZeroTouch as a modality Live pages and Catalog Only a display label in the briefing; no live occurrence Resolved [A:A5.2] [F:F0.1]
16 3,184 sitemap /s/ URLs with noindex brand pages versus indexable orphans Live robots and sitemaps Brand /s/ pages are noindex, /dp/ is indexable but absent from sitemap and internal links Open, ownership unknown [A:A2.1]
17 redirect_url points to a Vercel host behind SSO Live Set-Cookie plus host behavior If consumed as an absolute URL, the patient hits Vercel SSO Open [A:A8] [LIVE Set-Cookie headers]
18 "$30 typical insurance copay" for labs versus insurance_price: null Live lab SKUs The $30 is an estimate constant, not a benefit Resolved [F:F5.2] [CODE types/enums/lab-pricing-constants.ts:13]
19 "80% of customers pay $25 or less" Marketing copy only Not independently verified Open, marketing claim [LIVE /p/lilly/weight-loss]
20 Support hours and contact sprawl FAQ, consent, widgets, evidence-E and evidence-F Same 12-hour support window, different labels; individual clinician shifts are 4 to 6 hours inside it. Contacts include help@generalmedicine.co, hello@generalmedicine.co, support@navhealth.co, (801) 251-6055 and (801) 255-6051. Tenant, purpose and ownership need reconciliation before publishing one DTC contact Open [F:F3.2] [LIVE /faq] [LIVE /telehealth-informed-consent] [E:E3]
21 Zendesk as patient support or clinician chat Physician posting plus patient bundle Confirmed clinician chat; patient support boundary unknown Open [F:F3.2] [LIVE Ashby FT Physician]
22 Metabase is publicly reachable Live GET Login shell reached; the reviewed response requires sign-in. Unauthenticated access to protected data was not established; SSO and permissions need review Open, security review [F:F4.1]
23 5-phase GLP-1 progression Public guide plus SKU prices Synthesis, not an observed pathway object Open [F:F0.1] [DOC briefing slide 35]
24 Video available in all 50 states versus licensure coverage Live sku_options plus posting requirements Video option returned for all states; clinician supply, licensure and state enforcement not guaranteed Open [B:B12] [F:F3.4]
25 signup_complete may not fire on the GLP-1 CTA path Code mount point plus redirect Tracker mount, fetchUser, analytics availability and a local flag all gate the call. Firing on this path was not observed Open [A:A8] [CODE components/SignupTracker.tsx:16-98]
26 price_guarantee_eligible:false versus checkout price_guaranteed flags Live SKU plus analytics No guarantee on this path; checkout flags may be generic Resolved, no guarantee [A:A5.4] [CODE lib/analytics/checkoutAnalytics.ts:63-64]
27 Lab results "48 hours" Product copy only No measured SLA Open [C:C21] [LIVE /resources/labs-faqs]
28 Insurance discovery vendor Verified candidate plus Waystar hosts Both plausible; no payload observed. Diagram uses "Eligibility service" and "Clearinghouse" Open [B:H5] [B:H8]
29 Persona trigger for GLP-1 Code routes plus generic pre-visit requirement Trigger unknown; a later gate cannot be excluded Open [B:H22] [CODE lib/store/api/updatesApi.ts:76-80]
30 Who collects the $299 Public article plus order schema Pay-ahead is retail-only; mail order pays the pharmacy; schema does not distinguish Open [D:D4.3] [C:C13]
31 Mounjaro is described as a Zepbound variant Mounjaro PI plus evidence-D catalog Separate T2D and CV-risk indication, separate NDC, retail-only observed route at $552.28 to $565.63; Zepbound self-pay ladder does not apply Resolved as a separate branch, price snapshot open [PUBLIC Mounjaro PI §1] [D:D4.2]
32 Cash mail order shown as two payments Pay-ahead article plus evidence-D Mail order is excluded from GM pay-ahead; patient pays the dispensing pharmacy once. Diagram corrected Resolved [D:D4.3] [LIVE /resources/compare-medication-prices-before-you-order-and-pay-ahead-for-easy-pickup]
33 Week-4 check-in shown at T+28 Four-dose supply arithmetic plus generic criteria API One KwikPen supplies four weekly doses, used by T+21; the next dose is due T+28. Starting refill work at T+28 can miss it. Proposed control is T+14 to T+18 refill start and backward planning; T+21 eRx alone does not guarantee mail-order delivery Open, proposed control [PUBLIC Zepbound PI §2.1] [PUBLIC https://www.lilly.com/lillydirect/faq] [E:E5]
34 Click clock and treatment clock share one column Timeline arithmetic E0 is click; T0 is first actual dose, patient-reported or evidenced. The clocks differ by the unknown Dstart; no bounded interval is established Resolved in text, data gap remains [INFERENCE]

12.2 Open questions

  1. Which Google queries drive organic sessions and conversions? No Search Console export was available.
  2. Is GM running paid media at scale, and are conversions uploaded server-side? No pixel exists.
  3. Does the post-auth flow use the full redirect_url or only its pathname?
  4. Does signup_complete fire on the Lilly and GLP-1 CTA path?
  5. Who owns sitemap generation, and why are noindex URLs included while indexable pages are omitted?
  6. Is the $1,074.09 default a clinical preference or a catalog artifact?
  7. Which Zepbound SKU do paid campaigns and prescribers actually use?
  8. Are the vial SKUs real products, and why is there no cash price?
  9. Is there a BAA with Segment, Datadog, Google, OneSignal, Sanity, Slack, Metabase, or the LLM vendor?
  10. Is 100 percent session replay lawful on clinical pages?
  11. Is ZeroTouch a product or only a Catalog label?
  12. What is the cancellation fee amount?
  13. What pharmacy margin, if any, does GM earn?
  14. Does the screening questionnaire branch on BMI or contraindications before booking?
  15. Are Obesity 300513 and Weight Loss 300312 distinct protocols?
  16. What is the exact state-to-PC and state-to-clinician matrix?
  17. Is the Vital and OpenLoop consent used for GLP-1, or legacy?
  18. Does any GLP-1 case use async clinical review?
  19. Who submits a PA, in what tool, and what is the p50 and p90?
  20. Does an approval cover a dose change, or is a new PA required?
  21. Can a patient attach a manufacturer savings card in GM checkout?
  22. Does the week-4 step require a paid visit, a questionnaire, or either?
  23. What are the clinical SLAs for chat, video start, and review?
  24. Is there a server-side dispense or rejection feed from any pharmacy?
  25. Does GM ingest carrier tracking?
  26. Is default_quantity mL or pens?
  27. Who collects and remits the $299 on mail order?
  28. Who sponsors the GM card BIN, and what is the discount formula?
  29. Is the client pharmacy_delegated a typo, a legacy alias, or a real server value?
  30. What is the lab bundle composition at week 4 for tirzepatide?
  31. What is the patient-facing critical-result SLA?
  32. Are at-home lab kits supported?
  33. Which LLM and prompt version draft the care plan and the patient copilot answers?
  34. What are the CarePathway phase values for GLP-1?
  35. Is Zendesk also used for patient support, and is a BPO behind 98528?
  36. What happens when weekend and evening clinical coverage expands?
  37. Who executes refunds, in what tool, and against what SLA?
  38. What is the medication refund policy for an uncollected or canceled fill?
  39. Are receipts emailed, and is there a tax line?
  40. How does the 104-employee count split across clinical, operations, support, RCM, and engineering?
  41. Does GM issue a good-faith estimate for self-pay patients, and in what channel?
  42. Is there an accessibility, interpreter, or caregiver path for intake and visits?
  43. Are pen needles and sharps supplies included, sold, or only counseled?
  44. Does GM confirm patient possession after delivery, or only rely on the carrier scan?
  45. Where is contraception counseling recorded at initiation and at each escalation?
  46. Is a first-dose administration date captured, and from what source?
  47. Is the HIE notice stored as a consent record, or only presented by continuing?
  48. What is the current Mounjaro cash quote, PA route and savings eligibility for the T2D branch?
  49. Does the backend enforce state licensure and professional-entity routing, or only filter the visible clinician pool?
  50. How many outside parties are mandatory on one real journey, as opposed to exchange entries in the register?
  51. Which PA submission channel and vendor are actually used, if any?
  52. Does any pharmacy send a dispense, rejection or tracking feed back to GM?

13. Evidence key

13.1 Tags

Tag Meaning
[CODE path:line] Observed in the recovered first-party source under src/sources/first-party/
[LIVE url, date] Observed on the live public site or public API, read-only, on 2026-10-19
[DATA file → key] From a local dataset under osint/, for example internal_portals_recon.json or extracted_care_plans_and_journeys.json
[DOC file §section] From a dossier, AlphaSense report, or briefing appendix
[PUBLIC url] A public third-party source: label, vendor documentation, NPPES, manufacturer terms
[E:§6 q14] Open question 14 in evidence-E.md section 6
[INFERENCE] Reasoning that is not directly observed; the basis is stated inline
A:A1, B:B7, C:C4, D:D5.2 Step row or numbered subsection in the named evidence file. The step ID is the stable anchor; that row carries the exact code path, live URL, or dataset key.
[B:§5] Section 5 of evidence-B.md, covering signup failure branches at evidence-B.md:128-136. [B:B5] is reserved for the Verified review-info step at evidence-B.md:29.
H01 to H72 Register row in section 4
* on a register row On the cash path, including alternative pharmacy and lab channels
Observed A specific source artifact or public response was inspected; not the full patient workflow
Published A company or vendor representation, not a measured SLA
Proposed A recommended future contract or control
Recovery gap Implementation was not available in the inspected material
Mapping gap This document omits a required step
Inferred Deduced from hostnames, absence, or adjacent evidence; not seen directly

13.2 Main sources

  • Evidence files behind every A:–F: tag (each step row and handoff row carries its exact code path, live URL, or dataset key): Evidence A: acquisition, Evidence B: account and intake, Evidence C: checkout and labs, Evidence D: clinical review and pharmacy, Evidence E: weeks 1 to 4, Evidence F: backoffice and operating model. Markdown originals sit beside each page.
  • Recovered consumer app (src/sources/first-party/: app/, components/, lib/, contexts/, hooks/, config/, tenants/): browse in the Research Wiki source index.
  • Internal portal inventory: osint/internal_portals_recon.json, covering Visitron 98 routes and 91 RTK operations, Catalog 47 routes and 106 operations, Referrals 18 routes and 27 operations, Provider Chat 20 routes and 14 operations.
  • Live SKU, questionnaire, and care-plan payloads: osint/extracted_care_plans_and_journeys.json.
  • Sitemap and price census: osint/live_sitemap_skus.json.
  • Infrastructure and NPI catalog: osint/infra_npi_catalog.json.
  • Dossiers: architecture, API reference, data models, OpenAPI contract, market and leadership dossier, company overview.
  • AlphaSense reports: company primer, Oct 19, expert calls, Oct 18, primer snapshot, Oct 18.
  • Public manufacturer terms and labels: https://zepbound.lilly.com/savings, https://www.lilly.com/lillydirect/faq, https://www.lilly.com/lillydirect/zepbound, https://pi.lilly.com/us/zepbound-uspi.pdf, https://pi.lilly.com/us/mounjaro-uspi.pdf.
  • Public vendor documentation: https://docs.verified.inc/1-click-signup/overview, https://docs.verified.inc/1-click-health/overview, https://www.gifthealth.com/faq-topics/prescriptions-getting-started, https://docs.junction.com/lab/overview/orders-and-results, https://docs.junction.com/lab/results/critical-results, https://docs.junction.com/lab/workflow/redraws, https://surescripts.com/news-center/intelligence-in-action/interoperability/the-journey-of-an-electronic-prescription.
  • Public registries: https://npiregistry.cms.hhs.gov/api/, NPI records 1912889320, 1285084467, 1710671854, 1447011267, 1750195483, 1174333975, 1346050150.
  • Public policy pages: /cancellation-policy, /refund-policy-labs, /assignment-of-benefits, /telehealth-informed-consent, /vital-informed-consent, /privacy-policy, /hipaa-privacy-practices, /faq, /resources/using-a-glp-1-for-weight-loss, /resources/labs-faqs, /resources/medication-faqs, /using-zoom, /clinician-hiring.
  • Legal and program references: https://www.medicare.gov/coverage/weight-loss-drugs, https://www.cms.gov/initiatives/your-patient-rights/medical-bill-rights/get-help/guides-resources/what-good-faith-estimate, https://www.mbc.ca.gov/Resources/Medical-Resources/telehealth.aspx, https://www.law.cornell.edu/cfr/text/45/164.502, https://www.law.cornell.edu/cfr/text/45/164.524.
  • Hiring and operating model: https://api.ashbyhq.com/posting-api/job-board/general-medicine and the full-time physician, 1099 physician, 1099 nurse practitioner, care coordinator, NP licensure, and RCM postings.
  • Public market context: Walmart and LillyDirect retail pickup release, CNBC vial price report, Pharmacy Times manufacturer-direct analysis.

13.3 Handoff count method

Raw handoff rows by file: A 23, B 22, C 15, D 18, E 18, F 25, total 121. The register has 72 rows after three operations: merging duplicate vendors that appear in several slices (Stripe, Twilio, Segment, Datadog, LaunchDarkly, Metriport, Particle, Athena, DoseSpot, Arrive, labs, pharmacies); splitting counterparties that were grouped in one raw row but have distinct mechanisms (LillyDirect endpoint versus dispensing pharmacies; Amazon versus other retail; Emerald versus Ruby and Centennial); and adding three handoffs required by the assignment but absent from the six tables (CMS NPPES, CMS Medicare GLP-1 Bridge, and the unidentified LLM provider). The staff identity plane is separated from the patient Cognito row.

13.4 Known limits

  • No authenticated screen was observed. All account, checkout, pharmacy-order, and care-plan pages return 307 to /login without an account.
  • No pharmacy, payer, lab, BI, or records production system was accessed. A missing field in an inspected interface is a recovery gap, not proof of enterprise-wide absence.
  • The click-to-first-dose interval is not measured. T0 is patient-reported or evidenced, never inferred from payment, eRx, dispense or delivery.
  • The GLP-1 questionnaire text, the week-4 criteria set and blocking rule, the CarePathway phases, and the PA workflow are server-side and were not recovered.
  • Internal portal behavior comes from the recorded operation inventory, not a live authenticated session.
  • The mandatory-party count for one journey is not established. The register counts exchanges, companies, products and conditional branches separately.
  • Prices and published program terms move. Every price above is a 2026-10-19 observation and should be re-probed before use in a contract or a forecast.